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ABSTRACT

Dysregulation of inflammatory pathways is strongly implicated in cancers and auto
immune diseases. The most consequential of these pathways involves the nuclear translo
cation of NF- kB, a transcription factor that induces the transcription of multiple proteins
associated with cell survival, inflammation, proliferation and death. It is activated when
the fibroblast growth factor-inducible 14 kDa protein (Fn14), a trimeric receptor recruits
its ligand, TWEAK. Studies have shown that Fn14 is over-expressed in many tumors, the
aggressiveness of which is often correlated with the degree of upregulation. Furthermore,
TWEAK-Fn14 activation has been shown to result in persistent NF-kB activation. Using a
mechanistic model of the signaling system, two specific features of the Fn14 pathway, (a)
the ability of Fn14 constitutive signaling and (b) NF- kB induced de novo Fn14 expression
were identified that give rise to positive feedback regulation and differentiate it from TN F-a
receptor signaling. Further analysis revealed that stimulation of Fn14 by TWEAK may
generate highly non-linear dynamics, including stable limit cycles and bistable responses.
Another critical contributor to the Fn14 signaling dynamics was found to be TWEAKdependent Fn14 trafficking dynamics. Rapid internalization allowed cells to show only
transient NF kB activity while lack of internalization was a significant factor in maintaining
the cell in a constitutively active state. Detailed study of Fn14 internalization, recycling and
degradation allowed the creation of a more comprehensive signaling model which is capable
of accounting for a wide range of Fn14 signaling behaviors observed in pathological tissues.
The model was further used as a platform for in silico studies of the effects of potential
targeted therapies on constitutively active cells such as those found in aggressive tumors.
The model predicts that two conventional therapeutic approaches - Fn14 antagonists and
anti-Fn14 siRNA - would provide unsatisfactory benefits while a novel approach involving
targeted degradation of the receptor could be promising avenue for developing anti-Fn14
therapeutics.
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1. INTRODUCTION

One of the hallmarks of all cancers is the ability of tumors to induce a persistent in
flammatory environment [Hanahan and Weinberg, 2011]. Inflammation causes the immune
system to supply neoplastic lesions with oncogenic bio-molecules such as survival factors
that help evade apoptosis, growth factors that help sustain proliferation, pro-angiogenic fac
tors which enhance blood supply to the tumor, and inductive signals that lead to activation
of epithelial-mesenchymal transition [Grivennikov et al., 2010]. A crucial mechanism em
ployed by tumor cells to accomplish this is the persistent activation of the NF- kB pathway
[Xia et al., 2014]. The NF- kB transcription factor induces the expression of a number of
pro-inflammatory cytokines which recruit the innate and adaptive immune-system to en
able tumorigenesis. Among the large number of cytokine-receptor systems that can induce
NF- kB activation is the receptor Fn14 and its ligand, TWEAK.

1.1. THE TWEAK CYTOKINE AND THE FN14 RECEPTOR
Tumor necrosis factor (TNF)-related weak inducer of apoptosis (TWEAK) is a
pro-inflammatory cytokine excreted by various tissues especially in response to injury
[Chicheportiche et al., 1997]. It binds with the fibroblast growth factor-inducible 14 (Fn14)
receptor (Figure 1.1) which is a type I transmembrane protein of the tumor necrosis factor
receptor (TNFR) superfamily [Bossen et al., 2006]. Although Fn14 is found at low levels
throughout the body, it is particularly over-expressed in solid tumors and at the site of tissue
injury [Perez et al., 2016]. In particular, Fn14 overexpression is seen in lung, breast and
oesophagal cancer, melanoma and glioblastoma [Tran et al., 2003, 2006; Whitsett et al.,
2012; Zhou et al., 2014]. In fact, Fn14 levels are highest in the most aggressive cancers
such as metastasized breast, lung and colorectal cancers [Whitsett et al., 2014; Yin et al.,
2014; Zhou et al., 2013], and these levels correlate strongly with poor prognosis for the
patient [Perez et al., 2016; Pettersen et al., 2013; Tran et al., 2006; Watts et al., 2007].
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Figure 1.1. TWEAK-Fn14 interaction. The trimeric ligand TWEAK is recruited by
Fn14 receptors on the cell surface, usually found as monomers. TWEAK then induces
trimerization by recruiting nearby Fn14 monomers to the complex. The receptor trimer is
the active signaling species.

Activation of Fn14 by TWEAK recruitment to the cell plasma membrane triggers
multiple intracellular signaling pathways associated with cell growth, proliferation, migra
tion, and apoptosis [Burkly et al., 2007; Donohue et al., 2003; Justo et al., 2006; Polek

et al., 2003; Tran et al., 2003, 2005]. This is analogous to other members of the TNF
ligand superfamily such as TN F-a and its receptor TN F-aR which is the most extensively
studied member or this family. However, TWEAK-Fn14 signaling differs in crucial ways
to T N F -a-T N F-aR signaling. The most salient distinction between the two pathways is
that stimulation of Fn14 by TWEAK induces persistent NF- kB activation [Colleran et al.,
2011; Dogra et al., 2006; Gomez et al., 2016; Saitoh et al., 2003; Sanz et al., 2008; Tran

et al., 2006]. This is in contrast to the more-well studied TN F-aR system where a number
of studies show a transient NF-kB activation in response to sustained TN F-a stimulation
[Lee et al., 2000, 2014; Maecker et al., 2005; Quivy et al., 2002; Rogers and Fuseler, 2007;
Saitoh et al., 2003].
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Despite the many similarities in the downstream protein interactions of the Fn14
and the TN Fa pathways, there is experimental evidence for two uniqe interactions in the
Fn14 pathway which could give rise to the significantly different behaviors. Firstly, Fn14
can activate without requiring stimulation by TWEAK when it is overexpressed on the cell
surface [Brown et al., 2013; Winkles, 2008]. Secondly, Fn14 induced nuclear localization
of NF- kB can itself induce the expression of the Fn14 gene and de novo synthesis of the
protein [Tran et al., 2006]. Thus, it can potentially give rise to positive feedback regulation
in the system [Kwon et al., 2014; Tran et al., 2006]. We may hypothesize that a cell when
stimulated with TWEAK activates the NF- kB pathway resulting in Fn14 expression. This
may result in Fn14 overcrowing on the plasma membrane which may allow the signal to be
sustained without requiring TWEAK stimulation.

1.2. MODELING THE NF-kB PATHWAY
The localization of the transcription factor NF- kB to the nucleus is a central step in
most immune responses [Pahl, 1999]. This can be triggered by a diverse range of stimuli
such as viral [Hiscott et al., 2006] or bacterial infections [Laflamme and Rivest, 2001],
inflammatory cytokines, free radicals [Bubici et al., 2006] and DNA damage [Bender et al.,
1998]. NF- kB is ubiquitously present in an inactive form in the cytoplasm bound to its
inhibitor I kB®. Activation of the pathway leads to destruction of I kB® thereby allowing
NF- kB to rapidly translocate to the nucleus where it binds to specific sites on the genome
and triggers transcription of various genes [Brasier, 2006].
Since the first mathematical model of the NF- kB pathway was published by Hoffman
et al in 2002 [Hoffmann et al., 2002], significant advances have been made by incorporating
more protein interactions in the model resulting in comprehensive models that can account
for a wide range of experimental observations [Basak et al., 2007; Cheong et al., 2008;
Hoffmann et al., 2006; Kearns et al., 2006; O’Dea et al., 2007]. With the inclusion of the
inhibitors iKBa and A20, these models show oscillations in NF- kB levels which was seen in
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single cells in wet experiments [Hoffmann etal., 2006] but not at the population level. This
was resolved by Paszek et al [Paszek et al., 2010] using a semi-stochastic method which
accounts for cell to cell variation. They found that the heterogeneous oscillations at the
single cell level can give the impression of non-oscillatory behavior at the cell population
level [Williams et al., 2014]. Most recently, Basak et al. [Basak et al., 2007] and Shih et al.
[Shih et al., 2012] have augmented the model with the inclusion of the p100/I^Bd protein
which degrades to induce nuclear localization of non-canonical NF- kB.

1.3. MOTIVATION TO STUDY FN14 SIGNALING
The above mentioned models however deal exclusively with the TN F-aR system,
with the implication being that since other members of the TNF superfamily behave simi
larly, these models could act as satisfactory proxies for studying their signaling dynamics
as well. However, with the discovery of certain unique aspects of TWEAK-Fn14 signaling
such as ligand independent activation [Brown et al., 2013; Winkles, 2008], Fn14 de novo
synthesis [Tran et al., 2006] as well as non-canonical pathway activation [Burkly, 2015],
the Hoffman model may not be sufficient to explain the peculiar experimental behavior
of TWEAK-Fn14. Given the implications of Fn14 signaling in very lethal pathologies,
it has become necessary to develop a computational model which incorporates the most
up-to-date evidence of Fn14 signaling behavior. This has been the primary motivation for
the work presented in this dissertation.

1.4. RULE-BASED MODELING FOR SYSTEMS BIOLOGY
Rule-based modeling is a simple yet powerful approach to study dynamic biological
systems. A typical approach involves specifying a network of rational reaction rules and
species which follow these rules. This is known as the network topology. Sometimes,
the rates of these governing reactions are known but often they are not. In the latter case,
the numerical values of these rate constants are varied over a wide range and the general
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system behavior is observed. Deliberately varying these numbers reveals regions of sytem
behavior which might mimick experimental observations such as oscillations, switch on or
off behavior, noise filtering etc.
In the present study, the model was defined in BNGL [Faeder et al., 2009]. BNGL is
a machine-readable language that can be executed using several rule-based modeling tools
[Blinov et al., 2004; Colvin et al., 2010; Sneddon et al., 2011]. The language permits the
creation of mechanistic models considering the site-specific details of the molecules and
network species [Faeder et al., 2005]. In a BNGL-defined model, the protein molecules are
specified with coarse-grained features, such as domains and motifs. Rules are specified to
define the interaction and transformations of these features. We executed the model using
the rule-based modeling software BioNetGen [Harris et al., 2016]. BioNetGen evaluates
BNGL rules and calculates all possible species and reactions that can generate from the
site-specific interactions and transformations of the molecules in a model. The software
then generates a system of ordinary differential equations which govern the concentrations
of the species according to the specified reaction rules.

1.5. WHY BUILD COMPUTATIONAL MODELS?
With the advent of data-rich biological research techniques, such as DNA sequenc
ing, RNA sequencing and proteomics, computational models of biological processes are
becoming invaluable to scientific progress. In this data-rich landscape, the ability to recog
nize trends and patterns is an increasingly important means to generate hypotheses which
can be tested empirically using traditional techniques. Biological models are by their nature
incomplete, but so is human comprehension of the processes governing biological systems.
Instead, the key intellectual objective of modeling is to develop a system of interacting
essential components bound by rational rules which may account for the largest possible set
of experimental observations. Such a model may also provide a framework for interpreting
new biological data. Computational models may also allow the determination of the rel
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ative importance of various system components. Often, seemingly small perturbations in
a single component can have an enigmatically large effect on the system. For example, a
mutation offering even a minute survival advantage can rapidly take over a tumor [Waclaw

et al., 2015]. A simple set of interaction rules however is sufficient to explain the darwinian
takeover of advantageous mutations. In this way, interventions to a system can be focused to
target specific components which may give the most promising results. Conversely, models
can also help 'w eed-out' unpromising hypotheses. Multiple interventions to a system may
be tested in silico and those which target the less significant components will likely produce
the least effective results. In this way, computational models are powerful tools to inform
potential experimental design. This is especially true for biological models of disease
progression which can provide recommendations for potential therapeutic approaches.
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PAPER

I. ANALYSIS OF FN14-NF- kB SIGNALING RESPONSE DYNAMICS USING A
MECHANISTIC MODEL

J. Khetan, D. Barua
Department of Chemical & Biochemical Engineering
Missouri University of Science and Technology
Rolla, Missouri 65409
Tel: 573-341-4854
Email: baruad@mst.edu

abstract

Fn14 is a transmembrane receptor protein belonging to the tumor necrosis factor
receptor (TNFR) superfamily. Many experimental reports have shown that crosslinking of
the receptor by its extracellular ligand TWEAK induces prolonged activation of transcription
factor NF- kB. On the other hand it has been reported that the TNF-a receptor, which is a
more well-characterized member of the TNFR family, only transiently activates NF- kB in
response to TNF-a stimulation despite sharing many similar molecular interactions with
Fn14. Here, we investigate molecular mechanisms that enable Fn14 to display such behavior.
In particular, we focus on two specific features of the Fn14 pathway, which are absent in the
TNFR system, that potentially give rise to a positive feedback regulation. By developing
a mechanistic model, we analyze how these features may determine the dynamics of an
Fn14-NF-KB response. Our analysis reveals that stimulation of Fn14 by TWEAK may
generate highly non-linear dynamics, including stable limit cycles and bistable responses.
The type of response depends both on the strength and duration of a TWEAK signal. Our
predictions and analyses also show that the molecular interactions underlying the positive
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feedback explain the prolonged activation of NF- kB under certain parameter regimes. In
light of the model predictions, we propose possible deregulations of Fn14 leading to its
overexpression in solid tumors and tissue injuries.
Keywords:

Computational Modeling, Bifurcation analysis, Computational Modeling,

Rule-based modelling, Glioblastoma, TNFRSF12A, Cell signaling, Systems Biology

1. INTRODUCTION
The fibroblast growth factor-inducible 14 (Fn14) is a type I transmembrane protein
of the tumor necrosis factor receptor (TNFR) superfamily and a prominent marker for several
pathological conditions, including glioblastoma multiforme [Burkly et al., 2007; Feng et al.,
2000; Lu et al., 2011; van Kuijk et al., 2010; Winkles, 2008; Zheng and Burkly, 2008].
Activation of Fn14 in the cell plasma membrane triggers multiple intracellular signaling
pathways associated with cell growth, proliferation, migration, and apoptosis [Burkly et al.,
2007; Donohue et al., 2003; Justo et al., 2006; Polek et al., 2003; Tran et al., 2003, 2005].
The receptor is activated by a soluble cytokine TWEAK, a member of the TNF ligand
superfamily. Activated Fn14 then activates the canonical NF- kB pathway in a way similar
to the TN F-a receptor (TNF-aR), which is an important and extensively studied receptor
of the TNFR family.
Experimental studies spanning the past two decades highlighted a specific charac
teristic of the Fn14 signaling pathway. It has been demonstrated that stimulation of Fn14
by TWEAK generates prolonged signaling and NF- kB activation [Colleran et al., 2011;
Dogra et al., 2006; Gomez et al., 2016; Saitoh et al., 2003; Sanz et al., 2008; Tran et al.,
2006]. Recent experimental reports indicate that the canonical NF- kB signaling cascade is
involved in this prolonged and sustained activation process [Colleran et al., 2011; Dogra

et al., 2006; Gomez et al., 2016; Maecker et al., 2005; Sanz et al., 2008; Tran et al., 2006]
although an earlier work indicates the non-canonical NF- kB pathway could generate such
response [Saitoh et al., 2003]. This reported behavior in Fn14-induced sustained NF- kB
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activation differs from the more-well studied TN F-aR system in that in the latter case,
a number of studies show a transient NF-kB activation in response to sustained TN F-a
stimulation [Lee et al., 2000, 2014; Maecker et al., 2005; Quivy et al., 2002; Rogers and
Fuseler, 2007; Saitoh et al., 2003]. Both Fn14 and TN F-aR share many common and
similar protein-protein interactions that lead to NF- kB activation. Therefore, the specific
underlying mechanisms in the TWEAK-Fn14 and TN Fa-TN FaR systems that account for
this difference in experimental observation remain to be understood. This modeling study
was particularly motivated to investigate this unresolved question about Fn14 signaling.
Although activation of Fn14 and TN F-aR is followed by many common molecular
interactions, experimental reports indicate two key features that are unique to Fn14 sig
naling. Unlike the TNF-aR, Fn14 can be activated in a ligand-independent manner when
overexpressed in a cell [Brown et al., 2013; Winkles, 2008]. Furthermore, activation of
Fn14 can induce the expression of its own gene and de novo synthesis of the protein [Tran

et al., 2006]. Thus, it can potentially give rise to positive feedback regulation in the system
[Kwon et al., 2014; Tran et al., 2006]. Although the key molecular interactions that give
rise to these two distinct features are fairly well-established, their regulatory roles in Fn14
signaling remain unclear. We were particularly interested in dissecting these roles and
underlying molecular interactions in determining the Fn14 signaling response dynamics. In
particular, we sought to answer whether these features, unique to Fn14 only, could explain
the postulated positive feedback regulation and the prolonged NF- kB activation mentioned
earlier.
To date, a number of modeling studies analyzed the response behavior of the TNFa R pathway [Lipniacki et al., 2007; Pkalski et al., 2013; Tay et al., 2010]. By contrast,
to the best of our knowledge, there has been no theoretical or computational modeling
study on the Fn14 receptor system. In this work, we developed a computational model on
the Fn14-canonical NF- kB signaling pathway. The model incorporates the detailed sitespecific binding of TWEAK and Fn14 in the cell plasma membrane. It also incorporates
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the signaling events associated with NF- kB activation, Fn14 transcription, and constitutive
Fn14 assembly in the plasma membrane. We used the model to predict and analyze the
system under normal conditions and several possible deregulations. Our analysis indicates
that: (a) the above two features of the Fn14 pathway are tightly coupled and they together
generate prolonged NF- kB activation as reported in [Colleran et al., 2011; Dogra et al.,
2006; Gomez et al., 2016; Saitoh et al., 2003; Sanz et al., 2008; Tran et al., 2006] and (b)
it predicts such behavior can occur even in response to a transient TWEAK signal. These
two features jointly synergize a positive feedback loop that may generate highly nonlinear
dynamics, including sustained oscillation (stable limit cycles) and bistable responses. Based
on the model predictions and analysis, we provide possible explanations of prolonged NFkB

response in tissue injuries [Burkly, 2014; Hotta et al., 2011; Jakubowski et al., 2005;

Mittal et al., 2010a,b] and Fn14 overexpression in certain types of solid tumors [Michaelson
and Burkly, 2009; Tran et al., 2003].

2. METHODS
2.1. MODEL SPECIFICATION
We formulated the Fn14-NF-KB signaling pathway model as an ordinary differential
equation (ODE) model. The model describes biochemical interactions and transformations
of a list of signaling protein molecules in the Fn14-NF-KB signaling pathway. Each of these
interactions and transformations is detailed in the Supplemental Material (Appendix A).
An overall description of the model is provided in the Results section.
The model was defined in BNGL [Faeder et al., 2009].

BNGL is a machine-

readable language that can be executed using several rule-based modeling tools [Blinov

et al., 2004; Colvin et al., 2010; Sneddon et al., 2011]. The language permits the creation
of mechanistic models considering the site-specific details of the molecules and network
species [Faeder etal., 2005]. In a BNGL-defined model, the protein molecules are specified
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with coarse-grained features, such as domains and motifs. Rules are specified to define the
interaction and transformations of these features. Supplemental Material (Appendix A)
details BNGL notation of these molecules and the rules describing their non-covalent
binding and biochemical transformations. We executed the model using the rule-based
modeling software BioNetGen [Harris et al., 2016]. BioNetGen evaluates BNGL rules
and calculates all possible species and reactions that can generate from the site-specific
interactions and transformations of the molecules in a model. The network of our model
contains 45 distinct chemical species and 114 elementary reactions.

2.2. SIMULATION
Simulations were carried out using BioNetGen.

The software generates ODEs

describing the mass conservation of species in the network of a BNGL-defined model. It
also performs simulation using the numerical ODE solver package CVODE [Cohen et al.,
1996].

3. RESULTS
3.1. THE NF-kB MODEL
As mentioned earlier, we were particularly interested in this pathway for its two
distinctive features, which are not shared by the TNF-aR-NF-KB system. Figure 1 provides
a simple illustration of these two features. Fn14 crosslinking and activation occur both in
ligand (TWEAK)-dependent and independent manners. Moreover, Fn14 itself can induce
its own gene expression via the NF- kB pathway. Figure 2 details the molecular interactions
in the model showing how they give rise to these two features.
The model incorporates site-specific binding between TWEAK and Fn14 in the
cell plasma membrane. Because TWEAK naturally exists as a trimeric complex in solu
tion, we represent it by a single ligand molecule containing three identical Fn14 binding
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Figure 1. Receptor crosslinking and positive feedback in Fn14 signaling. Left: Ligand
recruitment activates NF- kB pathway promoting receptor transcription. Right: Receptor
overexpression leads to self-association and constitutive activity.

sites (Figure 2). These three sites sequentially bind three Fn14 molecules to form a 1:3
ligand-receptor complex. However, the interaction also generates intermediate 1:1 and 1:2
ligand-receptor complexes. Nevertheless, only the 1:3 complex represents the signalingcompetent species [Winkles, 2008]. Besides this TWEAK-mediated crosslinking, we also
consider constitutive Fn14 assembly that occurs in the absence of TWEAK (Figure 2). For
each Fn14 molecule, we consider two identical binding surfaces via which it can assemble
with other Fn14 molecules and generate receptor homodimers or homotrimers. The ho
motrimers undergo a ring-closure reaction (Figure 1) to generate a relatively more stable
complex. As in the case of ligand-mediated receptor crosslinking, only the homotrimers
represent signaling competent species. We consider all ligand-dependent and -independent
interactions reversible. Table A.2 provides a list of the forward and reverse rate constants
associated with these interactions. For the ligand-independent association, we consider an
affinity (equilibrium dissociation constant

) such that only 2% of the Fn14 molecules

remain in the trimeric form under the nominal condition. This nominal condition represents
the basal inactive state of the system.
The molecular events downstream of Fn14 trimerization belong to the classical
NF- kB pathway (Figure 2). We incorporate most of these events based on the T N F -aR NF- kB model of Tay et al. [Tay et al., 2010]. Briefly, Fn14 trimers activate a cytosolic
protein called I kB kinase kinase (IKKK). The activated IKKK (denoted as IKKKa in
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Figure 2. Signaling protein interactions incorporated in the Fn14-NF- kB pathway model.
Besides the ligand and receptor, there are 9 distinct intracellular molecules whose functional
states and interactions are illustrated. A black arrow indicates a transformation, a grey
arrow indicates a positive influence and a blunt arrow indicates inhibition. The BNGL rules
defining these interactions are provided in Appendix A, Computational Model.

Figure 2) directly phosphorylates and activates its downstream protein IKK. Subsequently,
the activated IKK protein (denoted as IKKa) phosphorylates another protein I kB« , which
is an inhibitor of NF- kB. In its basal unphosphorylated form, I kB« remains in complex
with NF- kB and inhibits its nuclear translocation. However, phosphorylation of I kBa by
IKK releases this protein from the complex, thus allowing NF- kB to translocate into the
nucleus. After nuclear translocation, NF- kB induces transcription of A20, IKBa, and Fn14
(Figure 2). A20 serves as an inhibitor of IKKK. Therefore, its transcription activates a
negative feedback in the system. Similarly, transcription of I KBa, which prohibits nuclear
translocation of NF- kB, also activates a negative feedback. Finally, transcription of Fn14
activates a positive feedback, as explained before in Figure 1.
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3.2. FN14 ACTIVATES SUSTAINED NF-kB RESPONSE AGAINST A TRANSIENT
EXPOSURE TO TWEAK
One of our primary interests was to study how Fn14 self-assembly and the positive
feedback in Fn14 gene expression may define the dynamical behavior of the system. These
two features are expected to distinguish the system from the TNF-a R-N F-KB pathway.
While a number of studies have shown that sustained TNF-a exposure may induce transient
NF- kB activation [Lee et al., 2000, 2014; Maecker et al., 2005; Quivy et al., 2002; Rogers
and Fuseler, 2007; Saitoh et al., 2003], it has been have reported that Fn14 stimulation by
TWEAK yields prolonged NF- kB activation [Maecker et al., 2005; Saitoh et al., 2003].
We investigated whether the model could explain this experimental observation. We first
predicted Fn14 and NF- kB responses under a pulse stimulation by TWEAK (Figure 3). Our
simulation resembled a washout experiment, where cells were first stimulated with TWEAK
for an hour and subsequently washed out by replacing the ligand-containing medium with a
ligand-free fresh medium. The dotted curves in Figure 3A and B illustrate this pulse input.
Consistent with experimental reports, the model predicted prolonged Fn14 expres
sion (Figure 3A) and NF- kB nuclear localization (Figure 3B). Despite the removal of ligand,
the system did not return to its initial steady-state or basal condition. Instead, it reached
a new state with significantly higher amounts of Fn14 and nuclear NF- kB. As mentioned
previously, the basal condition in our model accounts for only 2% receptor trimerization
via the constitutive receptor assembly. This small fraction of trimers maintains ~ 0 .2%
of NF- kB in the nucleus in the absence of TWEAK. However, the model predicted an
approximately 6-fold increase in Fn14 and a 14-fold increase in nuclear NF- kB after the
stimulation (Figure 3A and B, respectively).
To further investigate the dynamics of the system, we systematically varied the
dose and duration of the TWEAK pulse. The resulting responses revealed four distinct
dynamical states for the system depending on the dose and duration (Figure 4). In response
to a relatively weak or short pulse of TWEAK (10-3 ng/ml TWEAK for 1 min or 1 ng/ml
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Figure 3. Predicted Fn14 and NF- kB dynamics in response to a pulse stimulation. In
the simulation, cells were subject to a fixed concentration of extracellular TWEAK for 1
hour. The dotted grey curve in each panel represents this pulse input. The figure shows
two different responses: (A) Fn14 expression and (B) NF- kB nuclear localization. Both
responses are normalized by corresponding basal amounts.

TWEAK for 1 s), the system remained almost non-responsive. A moderate pulse (0.1 ng/ml
for 1 min or 1 ng/ml for 5 s) activated a transient response after which the system returned to
the initial basal state. A relatively strong pulse (1 ng/ml for 1-10 min) generated a sustained
oscillation (stable limit cycles). Finally, a persistent stimulation (a step input of 1 ng/ml
TWEAK) drove the system into a fully-activated steady-state condition.
Against a transient pulse of TWEAK signal, one would naturally expect to see a
transient response. In contrast, our model predicts sustained responses against very short
pulses of TWEAK (Figure 4).
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Figure 4. NF- kB dynamics under TWEAK pulses of different durations and strengths.
The upper panels represent NF- kB dynamics under a short (1 minute) pulse of variable
strengths. The lower panels represent NF- kB dynamics under a pulse of variable duration
but fixed strength (1 ng/mL TWEAK).

3.3. CONSTITUTIVE ASSEMBLY OF FN14 AND ITS SELF-INDUCED GENE EX
PRESSION ARE ESSENTIAL FOR THE SUSTAINED RESPONSE
Our predictions in Figure 4 provide an important insight into the molecular mech
anism that could be responsible for the prolonged NF- kB activation. It is possible that
the constitutive receptor assembly is the key to this behavior. Such assembly may prohibit
the system from returning to the basal state after a transient stimulation. When a thresh
old number of Fn14 populates in the plasma membrane in response to a stimulation, the
constitutive Fn14 assembly may generate an appreciable amount of receptor trimers. The
receptor trimers may then induce the expression of Fn14 gene further, thus leading to a
positive feedback loop in the system. As a result, the two features may perpetually sustain
signaling even though the ligand is washed away or depleted from the extracellular space.
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To investigate the speculations above, we used the model to predict how interven
tions in the two features above could impact the behavior of the system. Blocking Fn14
transcription by nuclear NF- kB should eliminate the positive feedback loop. On the hand,
prohibiting constitutive Fn14 self-assembly should impair its potential role in prolonging
responses discussed in the previous section. In the model, we implement the former inter
vention by setting the rate constant associated with Fn14 mRNA translation to zero. We
implement the latter intervention by setting the forward rate constant for constitutive Fn14
assembly to zero.
Figure 5 compares the responses of the compromised cells created through the
above two interventions. Both wild-type and compromised cells activated rapid responses
immediately after TWEAK exposure. However, unlike the wildtype cell, none of the two
compromised cells was able to sustain signaling. The difference became apparent at about
t > 10 h. The response of the wildtype cell eventually settled down to a constant-amplitude
oscillation (stable limit cycles) (Figure 5A). In contrast, the responses of the compromised
cells returned back to the basal inactive state within 10 h of stimulation (Figure 5B).
The result indicates that either intervention was adequate to abolish a cell's ability
to generate a self-sustained response. In the model, blocking Fn14 transcription by NF- kB
essentially keeps the amount of Fn14 in a cell fixed regardless of TWEAK stimulation.
Because the positive feedback is not activated, the system returns to its basal state after
generating a transient signal. On the other hand, when the constitutive receptor assembly
is blocked, the induced Fn14 expression in response to TWEAK does not contribute to
signaling after the ligand is washed away and the system returns to its basal state as well.
From Figure 5B, this latter intervention appears to have a more pronounced effect on
signaling.
The oscillations in Figure 5 could arise from a negative feedback in the NF-kB
cascade. This negative feedback is associated with transcription of A20, which acts as a
negative regulator of IKKK (Figure 2). The oscillations are relatively fast compared to the
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Figure 5. Comparison between wildtype and compromised (mutant) cell responses. All sim
ulations represent stimulation by a 10 minute 1 ng/ml TWEAK pulse. (A) Post-stimulation
nuclear NF- kB in a wildtype cell. (B) Post-stimulation nuclear NF- kB in compromised
cells. The solid curve represents a cell where NF-KB-mediated transcription of Fn14 was
blocked. The dotted curve represents a cell where Fn14 constitutive assembly was prohib
ited. (C) Phase portrait of Fn14 mRNA vs. nuclear NF-kB for a wildtype cell. (D) Phase
portrait of Fn14 mRNA vs. nuclear NF- kB for the two compromised cells (the solid and
dotted lines correspond to the cells in Panel B). In the panels, concentrations are presented
in terms of relative values with respect to the basal state of corresponding cells.

slow dynamics of Fn14 expression and NF- kB nuclear localization. In the wildtype cell, the
oscillations gradually turn into stable limit cycles with mean response significantly above
the basal condition. On the other hand, in the compromised cells, the oscillations decay
gradually and the system completely returns to the basal condition.
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3.4. BIFURCATION ANALYSIS REVEALS BISTABILITY IN FN14-NF-kB SIG
NALING
Biochemical network systems containing positive feedback regulations are often
characterized by bistable responses.

The rapid switch-like activation upon stimulation

(Figure 5) motivated us to interrogate such a possibility in the system. We first considered

K ’D as a bifurcation parameter in our analysis. This parameter, which is the equilibrium
dissociation constant for constitutive Fn14 self-assembly, defines the stability of Fn14
trimers formed in the absence of TWEAK. The value of K^ has not been quantified or
reported in the literature. However, as mentioned earlier, we assigned it a nominal value
such that a small fraction of receptors (< 2%) are incorporated in trimers in the absence of
TWEAK.
Figure 6A and B show bifurcation analysis on the wildtype system in the absence
of TWEAK. The system displayed only stable limit cycles at K^ < 4 uM. On the other
hand, it remained non-responsive and maintained the basal steady-state at K^ > 7.5 uM.
In between these values of K ^ , it displayed a coexistence of oscillation and nearly basal
steady-state condition. It should be noted that the nominal value for K^ used in the model
is 6.1 uM, which falls within the intermediate range.
We then investigated a second bifurcation parameter 6 = r1/r2, where r1 and r2 rep
resent the rate of IKKK activation by the constitutively-formed and TWEAK-crosslinked
Fn14 trimers, respectively (Table A.2, Appendix A). This parameter allows us to hypo
thetically consider a scenario where the signaling strength of a constitutively-formed Fn14
trimer is distinct from that of a TWEAK-crosslinked Fn14 trimer.

Figure 6C and D

show bifurcation plots for cellular Fn14 and nuclear NF- kB against 6. The plots indicate
two distinct steady-state conditions in addition to the intermediate oscillatory regime. At
0 < 6 < 3 x 10-4, the system remains in the non-responsive steady state. In contrast, at
6 > 1.6 x 10-3, the system displays a new steady-state condition, which corresponds to its
fully activated state. The coexistence of a steady state and stable limit cycles is seen in the
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Figure 6. Bifurcation analysis. Fn14 level and nuclear NF- kB are analyzed against two
bifurcation parameters K ’D and 5. Parameter KD represents the equilibrium dissociation
constant (binding affinity) for constitutive assembly of Fn14. Parameter 5 measures the
signaling strength of a constitutively formed Fn14 trimer relative to a TWEAK-crosslinked
Fn14 trimer. The four panels represent the following bifurcation curves: (A) Fn14 vs. KD.
(B) nuclear NF- kB vs. K *D. (C) Fn14 vs. 5. (D) nuclear NF- kB vs 5.

intermediate range 3 x 10-4 - 1.2 x 10-3. A purely oscillatory response is seen between
5 = 1.2 x 10-3 - 1.6 x 10-3. In summary, these bifurcation analyses indicate three distinct
long-time behaviors of the system. It can return to the non-responsive basal state, display
sustained oscillation, or reach a fully activated steady-state condition.
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3.5. MAPPING OF FN14-NF-kB SIGNALING DYNAMICS TO DISTINCT PARAM
ETER REGIMES
The three qualitatively distinct states revealed by our bifurcation analysis strongly
depended on 6 and K *D. Because the values of these two parameters are unknown, we
wanted to characterize the regimes where the system might display the above three states.
The mapping in Figure 7A shows how various combinations of these two parameters jointly
determine these long-time behaviors for the wildtype system in the absence of TWEAK.
Because the system should remain non-responsive without stimulation, these two parameters
should not fall in the S and a regimes, where it generates stable limit cycles or fully activated
steady-state response, respectively. However, it is possible that deregulation could change
either of these parameters and drive the system into these regions even in the absence of
stimulation. For example, a point mutation might lead to an increase in the affinity of
receptor self-assembly, thus leading to a smaller KD. As shown in the figure, at KD < 1.2
uM, the system could become auto-activated regardless of the value of 6. However, the
above mappings change dramatically in the presence of TWEAK, as shown in Figure 7B and
C. Both these panels correspond to a 1-hour pulse of TWEAK but the concentrations are
1 ng/ml and 1 mg/ml, respectively. Considering the system becomes activated under such
stimulations, it is unlikely that the two parameters fall in the non-responsive (y) region of
these two panels. Therefore, part of the y region in Figure 7A that falls in the S or a region
of the latter two panels could represent the feasible regime for these two parameters. In
summary, these bi-parametric mappings indicate the sensitivity of the model to the choice
of different combinations of two parameters KD and 6.
However, to investigate the sensitivity of the system further to the choice of our model
parameter values, we also investigated its responses against joint variations of the three
parameters introduced in this study (k*D = k-c/k c, 6 and d f ). Rather than systematically
varying these three parameters, we assigned distribution for each of them and randomly
sampled their values from these distributions. Figure 8A shows the assigned distributions
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Figure 7. Two parameter mapping of long-time NF- kB dynamics. (A) Distinct types of
NF- kB responses at t ~ to under various combinations of parameters 6 and
in the
absence of TWEAK. The regions indicated by y , p and a represent the basal steady-state,
sustained oscillation (stable limit cycles), and activated steady state, respectively. (B) The
same as Panel A when the system is stimulated for 1 hour with 1 ng/ml TWEAK. The
dashed lines represent corresponding boundaries under zero TWEAK (Panel A). (C) The
same as Panel B when the system is stimulated for 1 hour with 103 ng/ml TWEAK.

for these parameters. Each parameter was distributed log-normally with the mean taken as
the base parameter value listed in the Supplemental Material (Appendix A). The log standard
deviation was taken to be 0.3 for each parameter distribution. This standard deviation was
chosen so that the parameters take values that differ by 2 to 3 orders of corresponding base
values. Using the sampled parameters, we performed simulations considering a 10-minute
transient TWEAK exposure. We sampled 1,000 distinct combinations of the three parameter
values. Each sample essentially represents a distinct cell in a population whose parameter
values take the above-specified distributions. Therefore, our simulations generated 1,000
distinct time-series responses (trajectories) for 1,000 distinct cells.
The results from our simulations are plotted in Figure 8. For the entire population
of 1,000 cells above, we identified three possible responses - auto-activation independent of
TWEAK, TWEAK-induced sustained activation, and TWEAK-induced transient activation
(Figure 8B and C). Despite the wide distribution of the parameter values, the cells displayed
any of these three distinct response behaviors. Therefore, regardless of the parameter value
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we choose, the system is expected to generate any of these three qualitative behaviors.
Figure 8C show that for each qualitative behaviors, the three parameters are clustered in
the same region in the three-dimensional parameter space. These clusters are indicated by
the three color codes (red, green and blue). In general, low values of K*D and d f and high
values of 5 (the red cluster in Figure 8C) create a system that is always activated regardless
of the presence or absence of TWEAK due to Fn14 overexpression. At intermediate values
of these parameters (the blue cluster), the system is not activated in the absence of TWEAK
but exhibits sustained activation in response to a transient TWEAK stimulation. At large
values of KD and d f and low values of 5 (green region), the system exhibits a transient
response to a transient TWEAK stimulation. Panels D and E show corresponding results
result in response to a step dose of TWEAK. As one might expect, cells do not return to the
basal inactive state as long as the stimulation sustains.

4. DISCUSSION
In summary, we have provided a detailed analysis of how two unique regulatory
features of the Fn14-NF-KB system define its dynamical responses. Our results indicate
that Fn14’s ability to induce its own gene transcription [Kwon etal., 2014; Tran etal., 2006]
coupled with its ligand-independent self-assembly in the plasma membrane may give rise
to a positive feedback loop in the system. This positive feedback self-sustains signaling
after initial transient stimulation.

Furthermore, positive feedback gives rise to highly

nonlinear dynamics, including stable limit cycles and bistable responses in the system. The
experimental work of Tran et al. [Tran et al., 2006] first proposed that Fn14’s ability to
induce its own gene could give rise to a positive feedback regulation in the system. Here,
using the model, we show that the effectiveness of this feedback may largely depend on the
second feature, i.e., ligand-independent assembly of Fn14. The model indicates that the
two features function in a complementary fashion to regulate NF- kB dynamics and Fn14
expression. Our analysis suggests that compromising either of the two features abolishes
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Figure 8. Sensitivity of the model predictions to its parameter values. The model was
simulated using sampled values of K *D, 8, and d f . A total of 1,000 combinations of these
three parameters were sampled. Each sample represents a distinct cell in a population. (A)
The assigned lognormal distributions of K *D, 8, and d f . Vertical red bars represent the mean
(nominal values in Supplemental Material (Appendix A). Each distribution corresponds
to a log-scale standard deviation of 0.3. (B) Predicted responses considering 10-minute
TWEAK stimulation. Colors represent three distinct qualitative behaviors revealed by the
1,000 simulated cells: ligand independent auto-activation (red), ligand-induced prolonged
activation (blue) and ligand-induced transient activation (green). (C) Three dimensional
scatter plot of showing the three distinct behaviors of the 1,000 simulated cells. The
coordinate of each dot represents a distinct cell.
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the positive feedback loop and the self-sustained response. In addition, mutations, which
could potentially increase the affinity of Fn14 self-assembly, may lead to overexpression of
Fn14 and trigger a self-sustained response even in the absence of TWEAK stimulation.
A key contribution of our work is that it mechanistically explains the TWEAKinduced prolonged activation of NF- kB, an observation reported in many experimental
works [Colleran et al., 2011; Dogra et al., 2006; Gomez et al., 2016; Saitoh et al., 2003;
Sanz et al., 2008; Tran et al., 2006]. Most of these studies have indicated the canonical
NF- kB pathway involving in process. However, an earlier study by Saitoh et al. [Saitoh

et al., 2003] provides suggests a distinct mechanism involving the non-canonical pathway.
Our model includes the elements of the canonical pathway only and hence our proposed
mechanism aligns with these majority and more recent experimental studies [Colleran et al.,
2011; Dogra et al., 2006; Gomez et al., 2016; Sanz et al., 2008; Tran et al., 2006].
Importantly, the prediction for sustained response is valid for a definite parameter
regime, as shown in Figures 7 and 8, where we have explored a wide range of our key
model parameter values. It should be noted that our model is devoid of any element of
the non-canonical NF-kB pathway. It would be interesting to extend our model to include
this alternative pathway of NF- kB activation and study the mechanism reported in Saitoh
et al. [Saitoh et al., 2003]. However, the non-canonical NF- kB pathway is relatively less
well-characterized in the context of Fn14 signaling. Therefore, we limited our model to the
more well-established biological information associated with the Fn14-NF-KB signaling.
Our model indicates that positive feedback-induced bistability (Figure 6), essen
tially allows the system to respond in a switch-like manner (Figure 4). Depending on the
stimulation dose or duration, the model predicts four distinct response behaviors for the
system (Figure 4: 1) a basal or inactive steady-state; 2) a single pulse response, 3) sustained
oscillation or stable limit cycles, and 4) fully-activated steady-state condition. Below a
threshold level of exposure time, TWEAK is unable to activate the system. A weak and
short TWEAK pulse above this threshold may generate a single pulse response so that
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the returns to the basal inactive condition. A moderately strong stimulation or exposure
time may give rise to sustained oscillation or stable limit cycles. Finally, a relatively long
stimulation or step change in TWEAK drives the system into a fully-activated steady-state
regime. Both the stable limit cycles and the fully-activated regime may self-sustain even
if TWEAK is depleted or washed away after the temporal stimulation. This differs from
the TN F-a autocrine positive feedback loop [Coward et al., 2002; Rushworth et al., 2011;
Wu et al., 1993] which is entirely ligand-mediated and therefore is dependent on extracel
lular factors such as extracellular ligand concentration, proximity of other active cells etc.
Our TWEAK-Fn14 model predicts that activation could be sustained even after complete
washout of ligand which is generally not the case with transient TN F-a stimulation [Chatterjee et al., 2019; Hoffmann et al., 2002; Poppers et al., 2000; Turner et al., 2010; Werner

et al., 2008].
The distinct types of responses predicted by the model underscore a potential filtering
mechanism for cells. In normal physiological tissue, the positive feedback may distinguish
signaling cues from noise [Hornung and Barkai, 2008]. It may keep a cell non-responsive
under the stochastic noise of extracellular TWEAK that is not intended to activate signaling.
However, in a tissue injury, it may recognize a stronger or longer TWEAK signal and trigger
long-lasting responses. As shown in Figure 5, a few minutes of TWEAK exposure can lead
to self-sustained NF- kB activation and Fn14 expression (Figure 5). These results highlight
potential regulatory mechanisms whereby cellular expression of Fn14 could be controlled
in a normal condition or tissue injuries. In a tissue injury, a prolonged NF- kB activation
and Fn14 overexpression could be necessary for the healing process.
It should be noted that in most experimental settings, cells are exposed to a solution
containing a fixed amount of TWEAK for a certain period of time. The duration of such
exposure is typically longer than a minute. Our model indicates that stimulation for a small
duration could lead to self-sustained NF-kB activation. We propose that such experiments
should be done under short pulses of TWEAK stimulation. A systematic variation in
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the pulse duration and its impact on specific readouts, such as NF- kB activation or Fn14
expression, could provide new insights and validate the predicted molecular mechanisms
generating prolonged responses.
To date, it remains unclear what causes Fn14 overexpression in certain types of solid
tumors. It is possible that a tumor is subject to high fluxes of TWEAK signals. However,
besides TWEAK exposure, there could be other mechanisms behind such deregulation. Our
model indicates that the affinity of constitutive Fn14 assembly is critical for the positive
feedback loop (Figure 7). An increase in the affinity could make the system sensitive to
the low level of TWEAK. One can surmise a naturally occurring point mutation in Fn14
altering the affinity. Such a mutation may induce constitutive Fn14 trimerization beyond
a threshold and activate the system in the absence of TWEAK (Figure 7). An interesting
study will be to investigate if such mutations indeed occur in glioblastoma and other solid
tumor tissues, where Fn14 is routinely found overexpressed.
We propose two interventions in the pathway to investigate the mechanisms deter
mining its dynamics. Our predictions in Figure 6 and Figure 7 indicate how the system
response could be controlled by modulating the parameters 6 and K*D. Between these
two, K*d represents a more easily manipulable parameter. In the simulations, by altering the
value of K *d , we modulated the effectiveness of the positive feedback loop. An experimental
analog will be to introduce a mutation in the Fn14 molecule to alter KD and compromise its
ligand-independent assembly. Signaling responses resulting from such mutations may pro
vide valuable insights into Fn14 deregulation and overexpression in solid tumors and other
pathological conditions. Another intervention we propose is to block NF-KB-mediated ex
pression of the Fn14 gene. This should also abolish the positive feedback and the possibility
of auto-activation in the absence of TWEAK.
Our model, to our knowledge, is the first model developed for this system and it may
serve as an initial base-case model at this point. The model can be refined and extended as
new information becomes available. The ligand-receptor interactions of this model can be
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adapted to create models for other pathways that operate downstream of Fn14. Examples
include Fn14-mediated regulation of the non-classical NF- kB signaling pathway [Roos

et al., 2010] and the mitogen-activated protein kinase (MAPK) cascade.
Here, we formulated the model using the rule-based approach. The primary mo
tivation was to incorporate the site-specific TWEAK-Fn14 interaction and assembly in
the plasma membrane. However, we treated the rest of the protein molecules as feature
less chemical species following an earlier model of TN F-a receptor-NF-KB signaling [Tay

etal., 2010]. An extension considering the site-specific details of these downstream protein
molecules will provide a more predictive power and enable interrogation of the effects
of targeted mutations at binding domains or motifs of the molecules [Barua et al., 2007;
Barua and Hlavacek, 2013]. Nevertheless, such comprehensive models are computationally
challenging due to the large state-space dimension, as highlighted in [Faeder et al., 2005].
Recently, we and others have developed a model reduction technique to avoid such com
plexity in rule-based models [Erickson et al., 2019]. Alternatively, a tool implementing
network-free stochastic simulation, such as NFsim, could also be employed to incorporate
such details in the model [Sneddon et al., 2011].

5. CONCLUSION
This modeling study unravels a possible molecular mechanism that enables the Fn14
receptor to generate prolonged NF- kB responses after a transient stimulation. Although
many experimental works reported this behavior, the underlying molecular mechanisms
remained poorly understood. The study finds that Fn14’s ability to self-assemble in the
absence of its ligand TWEAK is a critical feature in determining the sustained NF- kB
response. The model predicts that Fn14 self-assembly along with de novo Fn14 synthesis
in response to Fn14 stimulation synergistically activates a positive feedback loop, which
contributes to the long-lasting signaling. The analyses reveal highly non-linear dynamics,
including stable limit cycles and bistable responses that could be activated by the positive
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feedback loop depending on the strength and duration of the extracellular TWEAK signal.
The study sheds lights into the mechanisms whereby de novo Fn14 synthesis can lead to
prolonged overexpression of the receptor in solid tumors and tissue injuries.
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ABSTRACT
TWEAK is a pro-inflammatory cytokine belonging to the TNF-superfamily and is
known to induce apoptosis, survival, proliferation and migration. It does so by interacting
with its only known receptor, Fn14. TWEAK-Fn14 interaction is known to induce activa
tion of the NF- kB pathway which results in the transcription of various pro-inflammatory
proteins. Studies have shown that TWEAK-Fn14 interaction promotes multiple hallmarks
of cancer such as invasion and migration, epithelial-mesenchymal transition and angio
genesis. Unlike the better studied TNFa-NF-KB pathway, Fn14 activation often results in
persistent NF- kB activation, This may be due to unique features like constitutive signaling
and self-induced Fn14 up-regulation, but no comprehensive computational models have
been published which might illuminate these mechanisms. Here we propose a detailed
TWEAK-Fn14-NF-KB model which takes into account its unique signaling behavior, rapid
receptor trafficking as well as the relative contributions of the canonical and non-canonical
NF- kB activation. We find that TWEAK does not cause significant Fn14 degradation
which allows prolonged NF- kB activation via the canonical pathway. Furthermore, single
cell data reveals that the non-canonical NF- kB is only a small contributor to overall nuclear
NF- kB levels. Our computational model faithfully describes the different behaviors of
Fn14-inactive and constitutively active cells found in tumors. We further perform in silico

36
tests of three targeted pathway attenuating therapies. We find that conventional therapies
such as receptor antagonists and siRNA treatment give modest results while a novel treat
ment involving targeted lysosomal degradation provides rapid and long-lasting pathway
attenuation.
Keywords: Computational Modeling, Rule-based modelling, Glioblastoma, TNFRSF12A,
Cell signaling, Systems Biology

1. INTRODUCTION
TWEAK is a pro-inflammatory cytokine excreted by various tissues especially in
response to injury [Chicheportiche et al., 1997]. It activates the inflammatory NF- kB
pathway by binding to its only known receptor, Fn14[Bossen et al., 2006]. Fn14 is known
to be significantly overexpressed in lung, cervical and oesophagal cancer, melanoma and
glioblastoma [Tran et al., 2003, 2006; Whitsett et al., 2012; Zhou et al., 2014]. High levels
of Fn14 are correlated with cancer aggressiveness such as in metastasized cervical, lung and
colorectal cancers [Whitsett et al., 2014; Yin et al., 2014; Zhou et al., 2013] as well as with
poor prognosis for the patient [Perez et al., 2016; Pettersen et al., 2013; Tran et al., 2006;
Watts etal., 2007]. Activation of Fn14 by TWEAK recruitment to the cell plasma membrane
triggers multiple intracellular signaling pathways associated with cell growth, proliferation,
migration, and apoptosis [Burkly et al., 2007; Donohue et al., 2003; Justo et al., 2006;
Polek et al., 2003; Tran et al., 2003, 2005]. This is analogous to other members of the TNF
ligand superfamily such as TN F-a and its receptor TN F-aR which is the most extensively
studied member or this family. However, TWEAK-Fn14 signaling differs in crucial ways
to T N F -a-T N F-aR signaling. The most salient distinction between the two pathways is
that stimulation of Fn14 by TWEAK induces persistent NF- kB activation [Colleran et al.,
2011; Dogra et al., 2006; Gomez et al., 2016; Saitoh et al., 2003; Sanz et al., 2008; Tran

et al., 2006]. This is in contrast to the more-well studied TN F-aR system where a number
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of studies show a transient NF- kB activation in response to sustained TN F-a stimulation
[Lee et al., 2000, 2014; Maecker et al., 2005; Quivy et al., 2002; Rogers and Fuseler, 2007;
Saitoh et al., 2003].
In our previous work [Khetan and Barua, 2019] we unidentified two uniqe interac
tions in the Fn14 pathway which could give rise chronic Fn14 overexpression. Firstly, Fn14
can activate without requiring stimulation by TWEAK when it is overexpressed on the cell
surface [Brown et al., 2013; Winkles, 2008]. Secondly, Fn14 induced nuclear localization
of NF- kB can itself induce the expression of the Fn14 gene and de novo synthesis of the
protein [Tran et al., 2006]. Thus, it can potentially give rise to positive feedback regulation
in the system [Kwon et al., 2014; Tran et al., 2006]. We may hypothesize that a cell when
stimulated with TWEAK activates the NF- kB pathway resulting in Fn14 expression. This
may result in Fn14 overcrowing on the plasma membrane which may allow the signal to be
sustained without requiring TWEAK stimulation.
The NF- kB pathway is most extensively studied by activation of the TN FaR receptor
by TNFa. Upon activation of the pathway by TN Fa, kinases act upon the cytoplasmic
complex of NF- kB and its inhibitor I kB®. The I kBa is then degraded thereby allowing NFkB

to rapidly translocate to the nucleus where it binds to specific sites on the genome and

triggers transcription of various genes [Brasier, 2006]. Over the past two decades a number
of detailed mathematical models for this pathway have been developed [Basak et al., 2007;
Cheong et al., 2008; Hoffmann et al., 2002, 2006; Kearns et al., 2006; O ’Dea et al., 2007].
The most recent model resulting from the culmination of the previously mentioned work is
by Paszek et al [Paszek et al., 2010] which uses a semi-stochastic method and incorporates
cell to cell variation. These models however deal exclusively with the TN F-aR system, with
the implication being that since other members of the TNF superfamily behave similarly,
these models could act as satisfactory proxies for studying their signaling dynamics as
well. However, with the discovery of certain unique aspects of TWEAK-Fn14 signaling
such as ligand independent activation [Brown et al., 2013; Winkles, 2008], Fn14 de novo
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synthesis [Tran et al., 2006] and strong non-canonical pathway activation [Burkly, 2015],
the Paszek model may not be sufficient to explain the peculiar experimental behavior of
TWEAK-Fn14. Given the implications of Fn14 signaling in very lethal pathologies, it has
become necessary to develop a computational model which incorporates the most up-todate evidence of Fn14 signaling behavior. Here we present a comprehensive TWEAK-Fn14
signaling model which accounts for the above mentioned aspects of the system and provides
a platform for future in-silico experiments.

2. METHODS
2.1. CELL CULTURE
MDAMB-231 cells were grown in RPMI 1640 medium (Corning Life Sciences)
supplemented with 10% fetal bovine serum (Gibco) and 1% penicillin/streptomycin (Gibco).
Approximately 100,000 cells were grown in each well of a 24 well plate. Cells were treated
with 100 ng/mL of recombinant human TWEAK (Peprotech cat. no. 310-06) for various
durations upto 12 hours before further analysis.

2.2. FLUORESCENCE MICROSCOPY
Whole cell staining of cellular proteins was performed by culturing cells as de
scribed before fixing and permeabilizing using the Image-iT Fix/Perm kit (Invitrogen)
using the manufacturer's protocol. Cells were then blocked with 3% Bovine serum albumin
in phosphate buffered saline. Fn14 proteins were stained with mouse IgG Item-4 antibody
(eBioscience) followed by anti-mouse FITC conjugates secondary antibody. NF- kB sub
units were stained using either anti-p65 or anti-p50 primary antibody followed by FITC or
PE conjugated secondary antibody. After sufficient washing, cells were analyzed under a
fluorescence microscope. Staining of only membrane bound Fn14 was accomplished with
the same procedure but without permeabilization.
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2.3. FLOW-CYTOMETRY
For surface Fn14 quantification, cells were grown as above, detached with trypsin
and immediately cooled on melting ice to arrest biological processes. This was followed
by fixation and staining with antibodies as described above. Cell membrane integrity was
determined by co-staining with propidium iodide (eBioscience). Cells were then analysed
using a flow cytometer (BD Accuri C6 Plus).

2.4. COMPUTATIONAL MODEL
We developed a Fn14-NF-KB signaling pathway model based on our previous work
[Khetan and Barua, 2019]. The model describes biochemical interactions and transforma
tions of a list of signaling protein molecules in the Fn14-NF-KB signaling pathway. In
addition to the various novel protein interactions introduced in our previous work, such
as Fn14 trimerization, Fn14 transcription etc. [Khetan and Barua, 2019], we now include
Fn14 receptor trafficing to the early endosome (with and without ligand recruitment), Fn14
recycling to the surface and activation of the non-canonical NF- kB pathway based on reac
tion rules published by Basak et al [Basak et al., 2007] and Shih et al [Shih et al., 2009]. The
model was defined in BNGL [Blinov et al., 2004; Faeder et al., 2009]. BNGL allows one to
define course-grained features of proteins such as binding sites and motifs. The interactions
between these proteins are governed by simple reaction rules with specified rate constants.
Based on these species and reaction rules, a list of potential species is generated each with as
associated ordinary differential equation governing its concentration [Faeder et al., 2005].
The model was executed using the software BioNetGen [Harris et al., 2016]. BioNetGen
evaluates BNGL rules and calculates all possible species and reactions that can generate
from the site-specific interactions and transformations of the molecules in a model.
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2.5. SIMULATION
Simulations were carried out using BioNetGen.

The software generates ODEs

describing the mass conservation of species in the network of a BNGL-defined model. It
also performs simulation using the numerical ODE solver package CVODE [Cohen et al.,
1996].

3. RESULTS AND DISCUSSION
3.1. TWEAK INDUCES RAPID FN14 INTERNALIZATION
Previous studies suggest that only a fraction of Fn14 is usually available on the
cell surface [Meighan-Mantha et al., 1999]. This could be in part due to the necessity to
keep Fn14 surface concentrations low in order to prevent self-trimerization and maintain
the cell in a non-active basal state. Fluorescence microscopy of unstimulated MDAMB231 cells with immunostained Fn14 reveals that indeed most of the Fn14 is internalized
into cytoplasmic components. (Figure 1 A). This preliminary finding was significant as it
suggested that intracellular trafficking of the Fn14 receptor may be a significant contribu
tor to TWEAK-Fn14 signaling dynamics and therefore cannot be overlooked. On further
investigation, we found that not only is most Fn14 not found on the surface, but that Fn14
is rapidly internalized upon TWEAK stimulation (Figure 1 B&C). We incubated cells with
an anti-human Fn14 primary antibody and then stimulated the cells with TWEAK. The
internalized Fn14 - being labeled with the primary antibody recruited at the surface - was
then stained with a FITC labeled secondary antibody following fixation and permeabilization. Figure 1 C shows that following TWEAK stimulation for 30 minutes, Fn14 is clearly
trafficked to intracellular compartments, significantly reducing the Fn14 available at the
surface for TWEAK recruitment. Such receptor trafficking behavior could significantly
affect the TWEAK-dependent pathway activation dynamics.
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Figure 1. Fn14 distribution in unstimulated and TWEAK treated cells. A, MDAMB231 cells were fixed, permeabilized and immunostained with anti-Fn14-FITC. Most Fn14
protein is localized to cytoplasmic vesicles (red) as opposed to on the cell surface (yellow).
B & C, Live cells were incubated for 15 mins with anti-Fn14 primary antibody, washed, then
treated with 100 ng/mL of TWEAK for 30 mins. Cells were then fixed and stained with antiFn14-FITC secondary antibody and DiO plasma membrane dye without permeabilization.
B and C show cells with or without TWEAK treatment.

We then investigated the rate of Fn14 internalization in response to TWEAK stim
ulus. In order to quantify the TWEAK induced internalization rate, cells were treated with
increasing durations of TWEAK, followed by detachment, cell-surface immunostaining for
Fn14 and flow-cytometry analysis. Since the cells were not permeabilized, only mem
brane bound Fn14 was stained while internalized Fn14 remained unstained. Exclusion of
membrane permeable cells was further insured by propidium iodide (PI) counter staining
and then gating the PI-positive cells out of the analysed data. Figure 2 shows the results
from flow-cytometry analysis. The left panel shows representative violin plots of plasma
membrane-bound Fn14 fluorescence in cells treated with TWEAK for 0, 5, 10, 20, 30, 45
and 60 mintes. Even 5 minutes of TWEAK stimulation is sufficient to induce a significant
reduction in FITC fluorescence indicating a rapid internalization of membrane-Fn14. How
ever, TWEAK, being an inducer of apoptosis, causes significant in vitro cytotoxicity beyond
45 minutes of stimulation (Supplementary Figure B.1.D, Appendix B). This led us to restrict
model fitting to 45 minutes, when most cells were still healthy. The right panel of Figure 2
shows the average fluorescence of 3 experiments of cells treated with TWEAK 100 ng/mL
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for 0, 5, 10, 20, 30 and 45 minutes. The sharp decline in surface fluorescence indicates
rapid internalization to a stable minimum of membrane-Fn14 in just 10 minutes. Since this
behavior is not seen in TN Fa and other superfamily members [Algeciras-Schimnich et al.,
2002], we identified ligand induced rapid internalization as another unique feature of the
TWEAK-Fn14 system.

Figure 2. Flow-cytometry analysis of Fn14 internalization. MDAMB-231 cells were treated
with 100 ng/mL of TWEAK for the indicated times. Cells were then detached and stained
with anti-Fn14 and FITC labeled antibodies without permeabilization and analyzed via
flow-cytometry. Permeabilized cells were excluded via PI staining. Left panel shows FITC
fluorescence histograms as violin plots for 0 to 60 minutes of TWEAK treatment. Box
plots delineate the 0.25 and 0.75 quantiles. Right panel shows averages fluorescence of 3
experiments with >50,000 cells each. Model fit of receptor internalization is shown with a
dashed line.
*The increase influorescence at 60 minutes coincides with a substantial increase in TWEAK
induced cytotoxicity (Supplementary Figure B.l.D), making the plotted data a representation
o f only living cells which do not represent the entire cell population. We therefore decided
to perform model fitting only up till the time when cytotoxicity is negligible, that is till 45
minutes. This model limitation is further discussed in the Conclusion.
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3.2. TWEAK INDUCED FN14 INTERNALIZATION IS NOT ASSOCIATED WITH
DEGRADATION
The rapid internalization of Fn14 receptors due to TWEAK stimulation naturally
leads to the question of the receptors’ ultimate fate once inside the cell. In previous studies
of other TN Fa super-family members, ligand induced internalization is often followed
by lysosomal degradation [Higuchi and Aggarwal, 1994; Tsujimoto and Vilcek, 1987] or
receptor recycling to the plasma membrane. To see if the same can be observed for Fn14,
we analyzed the location of internalized Fn14 by fluorescence microscopy. Cells were
incubated with anti-human Fn14 primary antibody for 15 minutes followed by washing and
further incubation with Lysotracker Deep Red and TWEAK for 45 minutes. Cells were
then fixed, permeabilized and immunostained with anti-FITC secondary antibody (Figure 3,
left). The Lysotracker dye is a pH responsive dye designed to stain acidified late-endosomal
and lysosomal compartments. Trafficking of proteins to these vesicles results in enzymatic
protein degradation. Contrary to expectations, we see that even after 45 minutes of TWEAK
stimulation, the green (Fn14) and red stained regions (lysosomes) are not co-located.

Figure 3. Intracellular fate of Fn14. Cells were treated together with 100 ng/mL of TWEAK
and Lysotracker dye for 45 mins and then fixed, permeabilized and immunostained with
anti-Fn14-FITC (green). The right panels show western-blot analysis to total Fn14 levels
after TWEAK stimulation 0, 15, 30, 45, and 60 minutes. The western blot quantification is
shown in the bar chart. Fn14 expression was normalized against y^-actin. Each bar shows
and average of 3 experiments with 105 cells each.
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This indicates that although Fn14 is strongly internalized, the vesicles containing
the internalized Fn14 do not progress to late endosomes or lysosomes.

This provides

evidence that following ligand mediated endocytosis, Fn14 is stored in the early endosome
for eventual recycling to the plasma membrane. Furthermore, we quantified total Fn14
concentration in cells treated with TWEAK for upto 60 minutes via western-blot analysis.
Figure 3B shows that the total Fn14 protein content is not significant altered in response
to TWEAK stimulation of two different doses. We take these two findings - the lack of
lysosomal trafficking of Fn14 and constant total Fn14 levels - as evidence that TWEAK does
not induce any significant expression or degradation of cellular Fn14 levels in MDAMB-231
cells. In other words, we infer that any signaling behavior dependent on Fn14 availability
my be attributed to the trafficking of Fn14 to and from the plasma membrane alone.

3.3. TWEAK MAINTAINS LONG-TERM CANONICAL NF-kB SIGNALING
We now turned our focus to the downstream effects of TWEAK-Fn14 signaling,
namely the activation of the NF- kB pathway. Localization of the NF- kB family of dimers
into the nucleus is mediated by two distinct but somewhat interrelated pathways: the
canonical and non-canonical pathways.

The canonical pathway results in the nuclear

localization of the p65 unit of the NF- kB dimer whereas the non-canonical pathway results
in nuclear localization of the p50 unit. Figure 4 shows the nuclear localization of the
p65 subunit of NF- kB. MDAMB-231 cells were stimulated with 100 ng/mL of TWEAK
followed by fixation, permeabilization and immunostaining with anti-human p65 labeled
with FITC. The top panel of Figure 4 shows p65 primarily localized in the cytoplasm
when not stimulated with TWEAK. The bottom panel shows that a significant fraction
of cytoplasmic p65 has been transported to the nucleus following TWEAK stimulation.
This nuclear localization of NF- kB proteins is a measure of pathway activation and was
quantified by the correlation of green and blue pixel intensities (Figure 4, right) as explained
below..
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Figure 4. Nuclear trafficking of NF- kB subunit p65. Cells were treated with 100 ng/mL
of TWEAK for 30 mins and fixed, permeabilized, and immunostained with anti-p65-FITC
and DAPI. Top and bottom panels show representative cells with or without TWEAK
stimulation. The right panels show scatter plots of green vs. blue pixel intensities and the
respective blue-green correlation coefficients. A low correlation coefficient (top) indicates
low nuclear localization of p65.

Image analysis of NF- kB trafficking was performed using a three step process. The
three steps are represented by panels A, B and C in Figure 5. Step A: First, cells were
treated with varying durations of TWEAK upto 6 hours. Then cells were immunostained
for p65-FITC (green) as well as p50-PE (red). Images were taken of large regions containing
approximately 1,000 cells each (Figure 5A). Step B: The green (or red in the case of the
non-canonical NF- kB subunit, p50) value of each pixel was plotted against its blue value
(DAPI, nuclear stain) on a scatter plot. The degree of correlation between green and blue
regions was used as a measure of NF- kB nuclear localization. This was quantified by
calculating the correlation coefficient of the green-blue values of each pixel (Figure 4 &
Figure 5B). Step C: The correlation coefficient for the green-blue values of each pixel was
then plotted for each TWEAK duration. The correlation coefficients were normalized such
that the maximum nuclear localization was quantified as 1 (Figure 5C). The same steps
were performed for the p50 NF- kB labeled with PE (red). Our data shows that the canonical
NF- kB pathway (quantified by p65 nuclear localization) is rapidly activated in response
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to TWEAK stimulus and remains active for upto 6 hours. In contrast, the non-canonical
pathway (quantified by p50 nuclear localization) is activated slowly and is not a significant
contributor to overall nuclear NF- kB levels even after 6 hours of TWEAK stimulation. This
seems to confirm our earlier finding that long-term NF- kB activation does not necessarily
require the activation of the non-canonical pathway and can be explained by canonical
pathway activation alone [Khetan and Barua, 2019].

3.4. EVALUATION OF POTENTIAL THERAPIES USING AN UPDATED TWEAKFN14-NF-kB MODEL
An ordinary differential equation based computational model for the TWEAK-Fn14
signaling system was first published by our group for the first time in 2019 [Khetan and
Barua, 2019]. This model was based on the TNF»-NF- kB model published by Tay et al.
[Tay et al., 2010] with the addition of reaction rules governing the unique trimerization
and constitutive activation behavior of Fn14. Using experimental data gathered in the
present study for ligand independent Fn14 receptor distribution, ligand mediated Fn14
receptor trafficking and the nuclear localization of the canonical and non-canonical NFkB

subunits, we updated our model with the addition of relevant reaction rules governing

these new findings. A complete list reaction rules, parameters and species can be found
in Appendix A of this dissertation. The updates to the model can be briefly summarized
as follows. We first chose Fn14 internalization (k int) and recycling rates (k rec) such that
an unstimulated cell at steady state has approximately 10% of its receptors on the plasma
membrane while the remaining 90% is maintained in the early endosomal compartment
(surface to internalized Fn14 ratio based on fluorescence data from Figure 1A). A small
fraction of the latter is degraded (reaction rate d f ) while a small amount of cytoplasmic
Fn14 is synthesized (reaction rate c4,f ) in order to maintain Fn14 homeostasis. The ligand
dependent internalization (kint,t) is kept much higher than ligand-independent internalization

(kint ) such that the membrane bound Fn14 levels to fit the data in Figure 2. Reaction rates
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Figure 5. Quantification of nuclear localization of NF- kB though image processing. A,
Fluorescence microscopy images of cells with and without TWEAK treatment. Cells were
fixed, permeabilized and stained for p65(green) and p50 (red). The right most panels show
merged channels along with DAPI nuclear stain (not shown separately). B, Green and
blue intensity values are plotted for each pixel. The degree of linearity of the data is a
measure of the nuclear localization of p65 proteins. Panel B shows representative data from
untreated (control) and 6 hour TWEAK stimulated MDAMB-231 cells. C, Normalized
NF- kB nuclear correlation values are plotted for TWEAK stimulation upto 6 hours.

of non-canonical NF- kB signal transduction steps have been described by Shih et al. [Shih

et al., 2012]. Briefly, their model involves signal transduction based on the p100/IKBdNF- kB cytoplasmic complex. Upon stimulation, the I kB£ protein is phosphorylated and
then degraded leaving the cytoplasmic NF- kB dimers to translocate to the nucleus. These
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reactions rule were incorporated into our model without much modification except for the
change in I kB5 phosphorylation rate by fitting the model to the data in Figure 5C (orange
curve). The degradation rate of phosphorylated I kB5 and the nuclear transport rate of p50
were assumed to be the same as the corresponding reactions in the canonical pathway owing
to similar size and structure of the proteins involved.
We now created two kinds of ’cells’, differentiated solely in their plasma membrane
Fn14 expression. The type 1 cell has low Fn14 expression on the plasma membrane (only
10%, as explained above) and represents normal, disease-free cells in our body. The type
2 cell has a high fraction of Fn14 on the plasma membrane, 30% (quantified from cervical
carcinoma HeLa cells [Gurunathan et al., 2014], Supplementary Figure B.2, Appendix B)
and represents Fn14 overexpressing tumor cells such as those of glioblastoma, melanoma,
metastatic cervical and lung carcinomas etc. The latter type of cell also shows persistent
NF- kB activation. Our previous study [Khetan and Barua, 2019] suggested that, owing
to the Fn14 constitutive activation positive feedback loop, these two types of cells may
be descriptions of two stable states within the same cell; a stable inactive state and an
oscillatory activated state. The cell may be able to switch ’on’ or ’off’ depending on various
stimuli. Consequently, it may also be possible to target the pathway using a variety of signal
attenuating therapies which may ’switch-off’ a pathologically activated cell. We test three
such potential therapies on our comprehensive model. Two of these therapies are familiar
to medical research: Fn14 trimer antagonist (Enavatuzumab, [Chao etal., 2013; Lam etal.,
2018; Ye et al., 2017]) and anti-Fn14 siRNA [Peng et al., 2018; Watts et al., 2007], while a
third therapy, targeted lysosomal degradation [Banik et al., 2020], is novel. Each ’therapy’
is simulated by targeting a particular reaction step and multiplying the reaction rate constant
by a constant A. Thus, if A = 10, it implies that the particular reaction rate constant has
been increased ten-fold.
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Figure 6. Single cell response dynamics to targeted treatments. A single Fn14-upregulated
cell was subjected to three kinds of pathway-attenuating treatments of varying intensity. In
each case, a particular protein reaction rate was increased or decreased by a factor of A. The
duration of treatment is indicated by the green shaded region. Cellular response is shown
by plotting nuclear NF- kB levels. A, Fn14 antagonist treatment is simulated by a reduction
in Fn14 trimerization rate, kc • A, for 24 hours followed by return to original conditions. B
siRNA treatment is simulated by increase in mRNA degradation rate, c4,fn14 •A, for 24 hours
followed by return to original conditions. C, LYTAC treatment is simulated by an increase
in Fn14 internalization rate, kint • A, for 6 hours followed by return to original conditions.

3.4.1. Therapy A: Antagonist Mediated Prevention of Fn14 Trimerization. As
discussed previously, TWEAK-dependent and TWEAK-independent trimerization of Fn14
is the critical first step in pathway activation. Bifurcation analysis conducted by Khetan et al.
[Khetan and Barua, 2019] suggests that a drop in Fn14 trimerization may be able to ’switch
off’ a constitutively activated cell. To investigate this, we subjected a type 2 (constitutively
active) cell to anti-trimerization treatment by reducing the Fn14 trimerization rate, kc by
A (Reaction rules 3 & 4). The new rate constant was kc • A where A = 10-1, 10-2 and
10-3 (Figure 6A). A = 10-3 results in the sharpest decline in Fn14 trimerization and hence
represents the most intense antagonist effect. The ’treatment’ lasted for 24 hours followed
by a return to the basal trimerization rate. Figure 6A shows that treatment results in a
gradual oscillatory decline in nuclear NF- kB levels to the basal inactive state. Furthermore,
the cell does not return to the previous constitutively active state upon cessation of therapy.
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3.4.2. Therapy B: Anti-Fn14 siRNA. Another crucial contributor of the Fn14
positive feedback loop has been identified as the NF- kB induced expression of Fn14. Thus
it seemed intuitive to test a potential siRNA based therapy to attenuate the feedback loop.
SiRNA’s mediate the RNA interference pathway by binding to mRNA’s with complementary
sequences and causing their degradation prior to translation into proteins. Here we simulate
anti-Fn14 siRNA treatment by increasing the Fn14 mRNA degradation rate, c3,f n14 by a
factor of X, where X = 10, 103 or 105. Figure 6B shows that siRNA treatment is capable of
lowering the nuclear NF- kB levels to a lower oscillatory state but this effect is transient and
the levels return to the previous levels after cessation of siRNA treatment. It is interesting
to note that even when the siRNA based attenuation is most intense, i.e. when the mRNA
degradation rate is increased by an order of 5, the nuclear NF- kB levels return to their
activated state after siRNA treatment subsides. This is primarily due to the fact that siRNA
prevents the expression of new Fn14 proteins but has no significant impact on Fn14 levels
already present in the cell. Since, we know that cellular Fn14 levels are largely stable over
time (Figure 3), the amount of Fn14 remaining in the cells could be sufficient to maintain
signal activation in therapeutically relevant timescales.
3.4.3. Therapy C: Targeted Lysosomal Trafficking of Membrane-Fn14. A ma
jor finding of the present study has been the rapid internalization of Fn14 in response to
TWEAK stimulus in cells that are not constitutively active. This behavior is a significant
contributor to the cell’s ability to return to the basal inactive state by reducing the number
of surface Fn14 receptors capable of partaking in signal activation. In fact we were able to
create a constitutively active cell (type 2 cell) simply by reducing the internalization rate to
keep approximately 30% of the Fn14 on the surface. We see in tumors such as glioblastoma
that overexpress surface Fn14 [Tran et al., 2006, 2005], that TWEAK does not trigger
any significant internalization. We therefore hypothesized that targeted internalization and
lysosomal degradation of the surface Fn14 could be potential therapeutic approach. Such
an approach would accomplish two tasks: (a) reduce surface Fn14 which initiates signaling
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and (b) reduce the overall amount of Fn14 already present in the cell, something that is not
possible with siRNA therapy. This can be accomplished by employing a newly developed
technology named lysosome-targeting chimaeras (LYTAC) by Banik et al. [Banik et al.,
2020]. Here, a protein targeting antibody is fused with lysosomal trafficking glycopeptides
to form a ’chimera’. When cells are treated with these chimeras, the target surface protein
is rapidly internalized and then trafficked to the lysosome for degradation. We simulated
such a treatment by simply increasing Fn14 trimer internalization rate,

by a factor X,

where X = 2, 5 or 10. Figure 6C shows that even with 6 hours of LYTAC treatment, the
nuclear NF- kB levels drop rapidly to the inactive basal state level. Even a modest two-fold
increase in the internalization rate results in long lasting NF- kB suppression after treatment
has subsided. This suggests a new and potentially significant method of ’switching-off’
Fn14-overactive cells.

4. CONCLUSION
TWEAK-dependent and TWEAK-independent Fn14 trafficking to and from the
plasma membrane was studied by fluorescence microscopy. We found that TWEAK me
diated Fn14 internalization is a critical self limiting mechanism employed by the cell to
maintain low NF- kB levels and prevent the cell from ’switching’ to the constitutively active
state. We also studied the cross-talk between canonical and non-canonical NF- kB activation
quantifying the nuclear localization of the p64 and p50 subunits of NF- kB. We found that
non-canonical NF- kB is only a small contributor the overall nuclear NF- kB levels and that
the canonical pathway is sufficient to account for long-term NF-kB activation in response
to TWEAK stimulus. For the first time, receptor internalization, receptor recycling and
non-canonical NF- kB activation was included in a comprehensive TWEAK-Fn14-NF-KB
pathway computational model using reaction rules written with BioNetGen. A significant
shortcoming of the present model however is that it does not account for ligand induced
cell death and its effect on the population level. TWEAK, being an inducer of apoptosis
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via multiple pathways, was seen to induce significant toxicity beyond 45 minutes of in vitro
stimulation (Supplementary Figure B.1.D). In this case, removal of a large number of cells
due to cell death may shift the population average protein levels (such as surface Fn14,
Figure 2A, 60 minutes) in ways that cannot yet be accounted for by the model. For instance,
if a hypothetical subpopulation of cells were insensitive to TWEAK induced apoptosis,
the present model could not explain the surface Fn14 levels in those cells. In the absence
of apoptotic pathways in the model, we decided to fit the model up till the point where
toxicity is still minimal. On the other hand, a more comprehensive model that includes
TWEAK induced apoptotic pathways may be developed to simulate that only a high surface
Fn14 expressing subpopulation remains after most cells have been killed by 60 minutes of
TWEAK. Ou future work on TWEAK-Fn14 modeling should include TWEAK induced
apoptosis and cell-to-cell variation, which are lacking in the current model.
Finally, this updated model was used to create two types of cells: (a) low-Fn14,
low NF- kB activity and (b) high-Fn14 and constitutively active NF- kB cells by simply
altering the steady-state surface Fn14 levels. Type 2 cells were used as a model for Fn14
overexpressing tumor cells such as those of glioblastoma etc., and three potential therapeutic
approaches were tested in silico. We found that intuitive approaches such as Fn14 antagonist
therapy or Fn14 siRNA therapy provided at best a modest ability to ’switch off’ constitutive
activity in the cell. However, a novel therapy involving targeted lysosomal degradation
of surface Fn14 showed a drastic and long-lasting reduction in NF- kB activity after a
relatively short treatment. This study for the first time provides a computational model
which is capable of accounting for a wide range of unique experimental observations of the
TWEAK-Fn14 signaling system and provides a useful platform for in silico experiments of
various protein targets in the pathway.
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SECTION

2. CONCLUSIONS

2.1. SUMMARY
2.1.1. Unique Fn14 Behavior Results in Positive Feedback Loop. Our model
predicts that the combination of two unique features of Fn14: (a) ligand independent
trimerization and (b) NF- kB induced Fn14 expression are necessary and sufficient to create
a positive feedback loop where activation of the pathway results in Fn14 expression which
in turn causes crowding of Fn14 receptors on the plasma membrane which may then
cause constitutive trimerization and ligand-independent activation. Such behavior has been
hypothesized but not studied thoroughly via a mechanistic model prior to this study.
2.1.2. System Bistability Leads to Switching Behavior. The induction of the
positive feedback loop results in highly non-linear system dynamics including a wide
bistable region over a range of two crucial parameters. The system is bistable between a
constitutively active oscillatory state and a stable inactive state. This allows us to predict
that cells may employ such dynamics to switch ’on’ or ’off’ pathway activation in response
to the intensity and duration of pro-NF-KB stimuli. This also suggests that it may be possible
to ’switch off’ a pathologically active cell by targeting key proteins in the pathway.
2.1.3. Persistent NF-kB Requires Certain Key Features. Our findings suggest
that, contrary to previous assumptions, the non-canonical NF- kB pathway may not be nec
essary to explain long term activation of NF- kB in response to TWEAK. We find that a pos
itive feedback loop in the canonical pathway alone is both necessary and sufficient to result
in persistent nuclear localization of NF- kB. Furthermore, fluorescence microscopy analysis
of non-canonical NF- kB distribution reveals only a minuscule amount of non-canonical
NF- kB p50 protein localization in the nucleus after long lasting TWEAK stimulation.
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2.1.4. Receptor Trafficking is Key Contributor to System Dynamics. Fn14 dis
tribution in unstimulated and TWEAK-stimulated cells shows that rapid internalization of
Fn14 is a crucial feature of this signaling pathway. Internalization prevents further signal
transduction and prevents a cell from accidentally 'sw itching' to the pathologically active
state in response to insignificant stimulus.
2.1.5. An Evaluation of Potential Anti-Fn14 Therapies. In silico tests of three
potential anti-Fn14 therapies reveals that familiar and intuitive interventions such as Fn14
antagonists and anti-Fn14 siRNA provide modest or short-lived benefits. However, a novel
targeted Fn14 degradation therapy provides rapid and long lasting attenuation of pathway
activation.

2.2. RECOMMENDATIONS FOR FUTURE WORK
TWEAK being a potent inducer of apoptosis in cancerous and non-cancerous cells
Chicheportiche etal. [1997], was seen to cause cytotoxicity during long in vitro incubation.
This has the potential to artificially skew protein quantification data towards only those
cells that survive TWEAK induced apoptosis. In the absence of apoptotic pathways in
the model, it became necessary to fit the model up till the point where toxicity is still
minimal. This points to strong need for a comprehensive model that includes TWEAK
induced apoptotic pathways which may simulate the behavior of cells over a whole range
of their susceptibility to TWEAK induced apoptosis. Our future work on TWEAK-Fn14
modeling should include TWEAK induced apoptosis and cell-to-cell variation, which are
lacking in the current model.
The question of Fn14 mediated activation of the non-canonical NF- kB and crosstalk
between canonical and non-canonical pathways remains largely unanswered. It is recom
mended to perform detailed single-cell level study of downstream proteins of each pathway
using methods employed in Paper II of this dissertation; namely intracellular distribution
via microscopy and cell-to-cell variation via flow-cytometry. In particular, since TWEAK
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is a known inducer of apoptosis, This will allow the model to be refined and eliminate a
significant number of unknown reaction rate parameters. Furthermore, it is yet to be deter
mined whether the human Fn14 gene promoter region has non-canonical NF- kB binding
sites (binding sites have already been discovered for the canonical NF- kB by Tran et al.
[Tran et al., 2006]). If indeed such sites exist, it implies that non-canonical NF- kB too is
capable of inducing Fn14 transcription, potentially giving rise to another positive feedback
loop in the signaling pathway.
Of the various anti-Fn14 therapies which have been described in literature, most
have not been investigated in terms of their underlying molecular effects. For example, the
mechanisms by which Enavatuzumab, a humanized Fn14 antagonist, attenuates Fn14-NFkB

activity are largely not understood. It is recommended that such therapies be evaluated

in the context of the present computational model in order to provide a more rational path
to safe and effective anti-Fn14 therapies.
Lastly, therapeutic approaches suggested in this study have not been experimentally
verified. It is recommended that antagonist therapy, siRNA therapy and LYTAC therapy
be performed on pathologically active tumor cells. In addition to their overall pathway
attenuating abilities, it is necessary to determine the molecular effects on the various
downstream proteins in response to each therapy.

APPENDIX A.
COMPUTATIONAL MODEL
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1. BIONETGEN RULES
Below we provide BNGL rules describing the protein-protein interactions and bio
chemical transformations in the model. These rules can be broadly divided into the following
steps: 1) Fn14 trimerization in the plasma membrane, 2) activation of the NF- kB pathway
and other downstream events. In our model, most of the molecular interactions and reactions
associated with Step 2 are taken from Tay et al. [Tay et al., 2010].

1.1. FN14 TRIMERIZATION IN THE PLASMA MEMBRANE
This step occurring in the cell plasma membrane deserves a more detailed expla
nation because it is still not very well-characterized experimentally.

We make certain

assumptions based on the available knowledge. We consider both TWEAK-induced and
constitutive Fn14 trimerization, as illustrated in Figure A.1 and Figure A.2.
TWEAK naturally remains as trimers in a solution. In the model, we represent such
trimers by a single ligand molecule with three identical binding sites for Fn14 (Figure A.2).
The ligand can first be recruited from solution to form a 1:1 ligand-receptor complex.
Subsequently, the remaining two unoccupied sites of the ligand can sequentially engage
more Fn14 to form 1:2 and 1:3 complexes (Figure A.2).

Figure A.1. TWEAK-mediated Fn14 trimerization. The trimeric form of TWEAK (three
black circles) can sequentially engage up to three Fn14 molecules in a complex.
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The constitutive trimerization requires each receptor molecule to have at least two
binding sites (Figure A.2). This allows the protein to form homodimers as an intermediate
complex. Moreover, because of the two sites, we consider the possibility of a ring structure,
as shown (Figure A.2). Once a linear trimer is formed, it undergoes a fast ring-closure step
to create the ring structure. In the model, we restrict maximum three receptors per complex,
thus prohibiting tetramer or larger complex formation via this constitutive interaction.

Receptors with vacant receptor
binding sites self associate

Figure A.2. Fn14 trimerization via constitutive self-assembly. Each Fn14 contains two
lateral ’arms’ to self-assemble with other Fn14 molecules. The reaction can generate
various chain and ring structures containing up to three receptor molecules in a complex.

In BNGL, we define the trimeric form of TWEAK as T W E A K (r,r,r), where each r
represents one receptor binding site. We define Fn14 as F n 1 4 ( l , r , r ) , where l represents
its sole TWEAK binding site and r represents two identical sites for constitutive self
association.
Rule 1: This BNGL rule describes reversible recruitment of a TWEAK molecule
from solution and formation of a 1:1 TWEAK-Fn14 complex. The forward and reverse rate
constants associated with the reactions defined by this rule are kon and ko ff, respectively.

TW EA K (r,r,r) + F n 1 4 (l) <-> T W E A K (r!1 ,r,r).F n 1 4 (l!1 ) k _ o n ,k _ o ff

(1)
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Rule 2: This rule describes a reversible intracomplex binding between TWEAK
and Fn14. A TWEAK can be recruited by a receptor which is already in a complex with
another receptor via the constitutive assembly. In such case, the recruited TWEAK may
use one of its unoccupied sites to rapidly engage the other (unoccupied) receptor in the
complex. The forward rate constant for this interaction is k o\ . The reverse rate constant

kof f is the same as in Rule 1.

TW EA K (r).Fn14(l) <-> T W E A K (r!1).F n14(l!1) k _ o 1 ,k _ o ff

(2)

Rule 3: This rule describes binding (crosslinking) between a Fn14-bound TWEAK
molecule and a free Fn14 molecule. It is distinct from Rule 2, which requires the two
receptors to be already in a complex. Associated forward rate constant is k c. The reverse
rate constant kof f is the same as in Rule 1.

T W E A K (r!1 ,r).F n 1 4 (l!1 ) + F n 1 4 (l) <->
T W E A K (r!1 ,r!2 ).F n 1 4 (l!1 ).F n 1 4 (l!2 ) k c ,k _ o f f

(3)

Rule 4: This rule defines self-association between Fn14 molecules via their constitu
tive binding sites. Associated forward and reverse rate constant are kc and k-c , respectively.
The forward rate constant is the same as that in Rule 3.

F n 1 4 (r) + F n 1 4 (r) <-> F n 1 4 ( r ! 1 ) .F n 1 4 ( r ! 1 ) k c ,k _ c

(4)

Rule 5: This rule defines an intracomplex binding between two receptors. It allows
the terminal Fn14 receptors of a linear trimer to bind and form a ring structure (see the last
two steps of Figure A.2). This fast intracomplex binding is associated with forward rate
constant k o2 and reverse rate constant k-c . The reverse rate constant is the same as that in
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Rule 4.

F n 1 4 ( l , r , r l 1 ) . F n 1 4 ( l , r ! 1 , r l 2 ) . F n 1 4 ( l , r ! 2 , r ) <->
F n 1 4 ( l , r ! 3 , r ! 1 ) . F n 1 4 ( l , r ! 1 , r ! 2 ) . F n 1 4 ( l , r ! 2 , r ! 3 ) k _ o 2 ,k _ c

(5)

1.2. ACTIVATION OF NF-kB AND OTHER EVENTS DOWNSTREAM OF FN14
We model most of these interactions, which follow Fn14 trimerization in the cell
plasma membrane, based on [Tay et al., 2010]. Fn14 receptor trimers, formed either via
constitutive assembly or TWEAK-mediated crosslinking, activate a protein called IKK
kinase (IKKK). The activated IKKK activates another protein called IKK. Activated IKK
phosphorylats a protein called IKBa.

In its unphosphorylated form, IKBa remains in

complex with NF kB in the cell cytoplasm and inhibits nuclear translocation (activation)
of NF kB. Phosphorylation of IKBa by IKK dissociates this protein from NF- kB. The
phosphorylated and free IKBa then degrades rapidly while the free NF kB translocates to
the nucleus. Upon nuclear entry, NF- kB mediates transcription of A20, IKBa and Fn14
genes and synthesizes respective mRNAs. The mRNAs are then translated to respective
proteins. The newly synthesized Fn14 proteins are added to the existing pool in the cell
plasma membrane.
Rule 6: This rule defines activation of IKKK by a TWEAK-crosslinked Fn14 trimer
in the plasma membrane (see Figure 2 in main text of Paper I). We denote the inactive and
active form of this protein as IKKKn and IKKKa, respectively. The rate of activation is
defined by the following function: kiKKKactivation = kA

0+ A

20 [Tay et al., 2010]. In this rate

expression, A20 represents cellular concentration of the A20 protein and kA20 represents
a Hill function constant. This rate expression accounts for the inhibitory effect of A20 on
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IKKK activation (see Figure 2 in main text).

IKKK_n + T W E A K (r !+ ,r! + ,r!+ ).F n 1 4 (l!+ ).F n 1 4 (l!+ ).F n 1 4 (l!+ ) ->
IKKK_a + T W E A K (r !+ ,r! + ,r!+ ).F n 1 4 (l!+ ).F n 1 4 (l!+ ).F n 1 4 (l!+ )
k _ IK K K a c tiv a tio n O

(6 )

Rule 7: This rule describes activation of IKKK by a constitutively-assembled Fn14
trimer, which is devoid of TWEAK. We consider only the stable trimers, which have a
ring structure, mediate this activation. The rate of activation is defined by the following
function: 8 x kiKKKactivation = 8 x kA o+ A20, where 0 < 8 < 1. This factor 8 incorporates a
possibility that the constitutively-formed Fn14 trimers are less effective in activating IKKK
compared to the TWEAK-crosslinked Fn14 trimers.

IKKK_n + F n 1 4 ( l , r ! + , r ! + ) . F n 1 4 ( l , r ! + , r ! + ) . F n 1 4 ( l , r ! + , r ! + ) ->
IKKK_a + F n 1 4 ( l , r ! + , r ! + ) . F n 1 4 ( l , r ! + , r ! + ) . F n 1 4 ( l , r ! + , r ! + )
k _ IK K K a c tiv a tio n ( )* d e lta

(7)

Rule 8: This rule describes IKKK inactivation in a first-order process. Associated
rate constant is defined as ki .

IKKK_a -> IKKK_n k _ i

(8)

Rule 9: This rule describes activation of IKK by its kinase IKKK. We denote
inactive and active IKK as IKKn and IKKa, respectively. The rate of activation is defined by
the following function: kiKKactivation = ki • IKKK^.

IKK_n -> IKK_a k_IK K activation()

(9)
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Rule 10: This rule defines deactivation of IKK by A20. The rate is described by
the following function: kiKKintermetiation = f j (k 2 + A20). In this expression, A20 is the
concentration of A20, and k2 and k3 are two constants.

IKK_a

-> IKK_i k _ IK K in te rm e tia tio n ()

(10)

Rules 11 and 12: These rules describe transition of IKK in between three different
states IKK, IKKjj-, and IKKn. The same rate constant k4 is associated with these transitions.

IKK_i -> IK K _ii k_4

(11)

IK K _ii -> IKK_n k_4

(12)

Rules 13, 14 and 15: These rules describe interaction of nuclear NF- kB with
the gene promoters of three different proteins. These proteins are A20, IuBa and Fn14.
Nuclear NF- kB is denoted as N F k B (lo c ~ n ,b in ). Here, b in denotes that NF- kB is not
bound to I kB® whereas b in ! 1 denotes NF- kB -I kBa binding as can be seen in the binding
reactions, Rule 28 and 29. The genes corresponding to the three proteins in their free states
are denoted as GA2®(st~®), G IkB a(st~® ) and G Fn14(st~® ), respectively. The NF- kBbound state of these genes are denoted as GA2®(st~1), G Ik B a (st~ 1 ) and G F n 1 4 (st~ 1 ),
respectively. All these rules are associated with the same rate constant q i.

N F k B (lo c ~ n ,b in ) + GA2®(st~®) -> N F k B (lo c ~ n ,b in ) + GA2®(st~1) q_1
(13)
N F k B (lo c ~ n ,b in ) + G IkB a(st~® ) -> N F k B (lo c ~ n ,b in ) + G Ik B a (st~ 1 ) q_1
(14)
N F k B (lo c ~ n ,b in ) + G Fn14(st~® ) -> N F k B (lo c ~ n ,b in ) + G F n 1 4 (st~ 1 ) q _ 1 f
(15)
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Rules 16, 17 and 18: These rules describe deactivation of the above three genes
by unphosphorylated nuclear I kB® with rate constant q2. Nuclear I kB® is denoted as
Ik B a (lo c ~ n ,p h o ~ ® ,b in ), where lo c ~ n designates its location in nucleus, and pho~®
designates its unphosphorylated state.

Ik B a (lo c ~ n ,p h o ~ ® ,b in ) + GA2®(st~1) ->
Ik B a (lo c ~ n ,p h o ~ ® ,b in ) + GA2®(st~®) q_2

(16)

Ik B a (lo c ~ n ,p h o ~ ® ,b in ) + G Ik B a (st~ 1 ) ->
Ik B a (lo c ~ n ,p h o ~ ® ,b in ) + G IkB a(st~® ) q_2

(17)

Ik B a (lo c ~ n ,p h o ~ ® ,b in ) + G F n 1 4 (st~ 1 ) ->
Ik B a (lo c ~ n ,p h o ~ ® ,b in ) + G Fn14(st~® ) q_2

(18)

Rules 19, 20 and 21: These three rules define transcription of the above three
genes into corresponding mRNAs. The mRNA molecules are denoted as A2®_mRNA(),
IkBa_mRNA(), and Fn14_mRNA(), respectively.

Because transcription is mediated by

NF- kB in all three cases, we consider the same rate constant c\.

GA2®(st~1) -> GA2®(st~1) + A2®_mRNA() c_1

(19)

G Ik B a (st~ 1 ) -> G Ik B a (st~ 1 ) + IkBa_mRNA() c_1

(20)

G F n 1 4 (st~ 1 ) -> G F n 1 4 (st~ 1 ) + Fn14_mRNA() c_1

(21 )
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Rules 22, 23 and 24: These rules define degradation of the above three mRNA
molecules. We consider the same rate constant c3 for these rules.

A2®_mRNA() -> ® c_3

(22 )

IkBa_mRNA() -> ® c_3

(23)

Fn14_mRNA() -> ® c_3

(24)

Rules 25, 26 and 27: These rules describe translation of above three mRNA
molecules into corresponding proteins. We consider the same rate constant c4 associated
with these rules.
A2®_mRNA() -> A2®_mRNA() + A2®() c_4

(25)

IkBa_mRNA() -> IkBa_mRNA() + Ik B a (lo c ~ c ,p h o ~ ® ,b in ) c_4

(26)

Fn14_mRNA() -> Fn14_mRNA() + F n 1 4 ( l , r , r ) c _ 4 f

(27)

Note that each of the above rule lumps together two different events: translation of
a protein and then its transport from the nucleus to their respective compartments. Thus,
the newly synthesized A20 and I kBa are assumed located in the cytoplasm and Fn14 is
assumed located in the plasma membrane.
Rule 28: This rule defines interaction between cytoplasmic NF- kB and I kB®.
These two molecules form a cytoplasmic NF- kB -I kBa complex. The binding is denoted
by b in !1 . The associated rate constant is a\.

N F k B (lo c ~ c ,b in ) + Ik B a (lo c ~ c ,p h o ~ ® ,b in ) ->
N F k B (lo c ~ c ,b in !1 ).I k B a (lo c ~ c ,p h o ~ ® ,b in !1 ) a_1

(28)
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Rule 29: This rule defines interaction between nuclear NF- kB and I kB®. These
two molecules form a nuclear NF- kB -I kB® complex. The reaction described by this rule
is similar to that in Rule 28. However, the rate constant is scaled through multiplying

a\ by the cytoplasmic to nuclear volume ratio kv. Thus, the associated rate constant is
kNFk BIk B = a1.kv .

N F k B (lo c ~ n ,b in ) + Ik B a (lo c ~ n ,p h o ~ ® ,b in ) ->
N F k B (lo c ~ n ,b in !1 ).Ik B a (lo c ~ n ,p h o ~ ® ,b in !1 ) k_NFkBIkB

(29)

Rule 30: This rule describes IKK-mediated phosphorylation of cytoplasmic free
I kB® with rate constant a2.

Ik B a (lo c ~ c ,p h o ~ ® ,b in ) + IKK_a -> Ik B a ( lo c ~ c ,p h o ~ p ,b in ) + IKK_a a_2
(30)
Rule 31: This rule describes IKK mediated phosphorylation of I kB® within the
cytoplasmic NF- kB -I kB® complex. Associated rate constant is a3.

N F k B (lo c ~ c ,b in !1 ).I k B a (lo c ~ c ,p h o ~ ® ,b in !1 ) + IKK_a ->
N F k B ( lo c ~ c ,b in ! 1 ) .I k B a ( lo c ~ c ,p h o ~ p ,b in ! 1 ) + IKK_a a_3

(31)

Rule 32: This rule describes degradation of A20 with rate constant c5.

A2®() -> ® c_5

(32)
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Rules 33 and 34: These two rules describe degradation of cytoplasmic phosphorylated and unphosphorylated I kB®, respectively. Associated rate constants are tp and c5a
respectively.
Ik B a ( lo c ~ c ,p h o ~ p ,b in ) -> ® t_ p

(33)

Ik B a (lo c ~ c ,p h o ~ ® ,b in ) -> ® c_5a

(34)

Rules 35 and 36: These two rules respectively describe ubiquitination (degradation)
of phosphorylated and unphosphorylated I kB® within the NF- kB -I kB® complex. These
reactions happen in a single step freeing NF- kB into the cytoplasm. The rate constants
associated are tp and c6a, respectively.

N F k B ( lo c ~ c ,b in ! 1 ) .I k B a ( lo c ~ c ,p h o ~ p ,b in ! 1 ) -> N F k B (lo c ~ c ,b in ) t_ p
(35)
N F k B ( lo c ~ c ,b in ! 1 ) .I k B a ( lo c ~ c ,p h o ~ 0 ,b in ! 1 ) -> N F k B (lo c ~ c ,b in ) c_ 6 a
(36)
Rules 37: This rule describes degradation of membrane Fn14. Corresponding rate
constant is d f .
F n14() -> 0 d _ f

(37)

Rules 38 and 39: These two rules respectively describe the transport of free cyto
plasmic NF- kB and unphosphorylated I kB® from the cytoplasm to the nucleus. Associated
rate constants are i1 and z'ia, respectively.

N F k B (lo c ~ c ,b in ) -> N F k B (lo c ~ n ,b in ) i_ 1

(38)

Ik B a ( lo c ~ c ,p h o ~ 0 ,b in ) -> Ik B a (lo c ~ n ,p h o ~ 0 ,b in ) i_ 1 a

(39)
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Rules 40 and 41: These rules respectively describe the export of free and NF- kBcomplexed I kB® from the nucleus to cytoplasm. Associated rate constants are e1a and e2a,
respectively.

Ik B a (lo c ~ n ,p h o ~ ® ,b in ) -> Ik B a (lo c ~ c ,p h o ~ ® ,b in ) e_1a

(40)

N F k B (lo c ~ n ,b in !1 ) .Ik B a ( lo c ~ n ,p h o ~ ® ,b in !1 ) ->
N F k B (lo c ~ c ,b in !1 ).I k B a (lo c ~ c ,p h o ~ ® ,b in !1 ) e_2a

(41)

2. MOLECULES AND COPY NUMBERS
Table A.1 provides the list of basic protein molecules and their nominal copy
numbers in the basal steady-state condition.

Table A.1. Molecules and their nominal copy numbers in cells.
Molecule

Copy number

#/cell

Ref.

Fn14

nfn14

1.3 x 104

Fick etal. [2012]

NF- kB

nnfkb

105

Tay et al. [2010]

IKK

niKK

105

Tay et al. [2010]

IKKK

nIKKK

2 x 105

Tay et al. [2010]

IKBa gene

nikba

2

Tay et al. [2010]

A20 gene

na20g

2

Tay et al. [2010]

Fn14 gene

nfn 14g

2

Tay et al. [2010]
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3. MODEL PARAMETERS

Table A.2 provides the list of parameters and their nominal values used in the model.

Table A.2. Model Parameters.
Description

Parameter

Value

Ref.

Rule 1: TWEAK (solution)-Fn14

kon

1.095 x 10-9

Fick et al.

molecule- 1.s-1

[2012 ]

0.58 x 10-3 s-1

Fick et al.

(membrane) binding 1
Rule 1: TWEAK-Fn14 dissociation

koff

[2012 ]
Rule 2: Fn14 homotrimer

ko1

7.3 x 103 s-1

ring-closure

Khetan
and Barua
[2019]

Rule 3: Constitutive Fn14

kc

association

1.095 x 10-7

Khetan

molecule- 1.s-1

and Barua
[2019]

Rule 4: Constitutive Fn14

k-c

1.6 s-1

Khetan

dissociation

and Barua
[2019]

Rule 5: TWEAK-Fn14 trimer
ring-closure

ko2

6.85 x 104 s-1

Khetan
and Barua
[2019]

Continued on next page
Tick et al. report kon in molar units to be 3.3 x 106 M-1-s-1 [Fick et al., 2012]. To be consistent
with the number units used in BioNetGen, kon is converted to units of molecule- 1-s-1 using the equation
kon = konmolar/(NA ■V), where NA is the Avogadro constant and V is the solution volume per cell. Cells
were cultured at a density of 2 x 105 cells/mL making V = 5 x 10-9 L/cell. = ^ kon = 3.3 x 106/(6.022 x
1023 x 5 x 10-9) = 1.095 x 10-9 molecule-1.s-1.
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Table A.2. Model Parameters. (cont.)
Description

Parameter

Rule 6 : IKKK activation by a

ka .kA20
k A2 0 +A20

Value

Ref.
Tay et al.

TWEAK-crosslinked Fn14 trimer

[2010 ]

ka

10-5 s-1

Tay et al.
[2010 ]

kA20

Tay et al.

105

[2010 ]
Rule 7: IKKK activation by a

O ka .kA20

Khetan

0 kA 2 0 +A20

constitutively assembled Fn14

and Barua

trimer

[2019]
£

2 x 10-4 - 10-2

Khetan
and Barua
[2019]

Rule 8 : IKKK inactivation

ki

10-2 s-1

Tay et al.
[2010 ]

Rule 9: IKK activation

ki • IK K K l

Tay et al.
[2010 ]

ki

6 x 10-10 s-1

Tay et al.
[2010 ]

Rule 10: IKK inactivation

Tay et al.

(k2 + A20) • |

[2010 ]

k2

104

Tay et al.
[2010 ]
C ontinued on n ext page
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Table A.2. Model Parameters. (cont.)
Description

Parameter

Value

Ref.

&3

2 x 104 s- 1

Tay et al.
[2010 ]

Rule 11, 12: IK K ,^IK K ,, and

&4

10- 3 s- 1

I K K ^ IK K n
Rule 13, 14: NF- kB binding to

[2010 ]
qi

4 x 10- 7 s- 1

A20 and IuBa gene promoters
Rule 15: NF- kB binding to Fn14

Tay et al.

Tay et al.
[2010 ]

qi f

1.2 x 10- 6 s- 1

gene promoter

Khetan
and Barua
[2019]

Rule 16, 17, 18: I kB® induced

q2

10- 6 s- 1

NF- kB release from gene

Tay et al.
[2010 ]

promoters
Rule 19, 20, 21: A20, I kBa , or

ci

10- 1 s- 1

Fn14 mRNA synthesis
Rule 22, 23, 24: A20, LrBa, or

[2010 ]

C3

7.5 x 10- 4 s- 1

Fn14 mRNA degradation
Rule 25, 26: A20 or I kB® mRNA

Tay et al.
[2010 ]

c4

0.5 s- 1

translation
Rule 27: Fn14 mRNA translation

Tay et al.

Tay et al.
[2010 ]

c4f

0.167 s- 1

Khetan
and Barua
[2019]

C ontinued on n ext page
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Table A.2. Model Parameters. (cont.)
Description

Parameter

Value

Ref.

Rule 28, 29: NF- kB and LrBa

a\

5 x 10-7 s-1

Tay et al.

association
Rule 30: Free iKBa

[2010 ]

a2

10-7 s-1

phosphorylation
Rule 31: IuBa phosphorylation in

[2010 ]

a3

5 x 10-7 s-1

NF- kB -I kB® complex
Rule 32: A20 protein degradation

Tay et al.

Tay et al.
[2010 ]

C5

5 x 10-4 s-1

Tay et al.
[2010 ]

Rule 33, 35:

tp

10-2 s-1

Phosphorylation-induced

Tay et al.
[2010 ]

degradation of I kBa
Rule 34: Spontaneous degradation

c5a

10- 4 s-1

of free IKBa
Rule 36: Spontaneous degradation

[2010 ]
c6a

2 x 10-5 s -1

of iKBa in NF- kB -I kBa complex
Rule 37: Fn14 degradation

Tay et al.

Tay et al.
[2010 ]

df

2.2 x 10-4 s-1

Khetan
and Barua
[2019]

Rule 38: NF- kB nuclear import

ii

10-2 s-1

Tay et al.
[2010 ]

C ontinued on n ext page
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Table A.2. Model Parameters. (cont.)
Description

Parameter

Value

Ref.

Rule 39: IuBa nuclear import

i\a

2 x 10-3 s -1

Tay et al.
[2010 ]

Rule 40: IuBa nuclear export

e1a

5 x 10-3 s-1

Tay et al.
[2010 ]

Rule 41: NF- kB nuclear export

^2a

5 x 10-2 s-1

Tay et al.
[2010 ]

Ratio of cytoplasmic to nuclear
volumes

kV

5

Tay et al.
[2010 ]

APPENDIX B.
SUPPLEMENTARY FIGURES
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FSC-A

FSC-A

Figure B.1. Flow-cytometry sequential gating and cell counting. MDAMB-231 cells were
grown on 24 well plates at a density of approximately 200,000 cells per well and treated
with TWEAK 100 ng/mL for up tp 60 minutes. Cells were detached and re-suspended in 1
mL of PBS for flow-cytometry. Flow-cytometry data was sequentially gated in 3 steps as
shown in panels A, B and C. (A) Removal of debris, (B) Removal of doublets, (C) Removal
of dead cells stained with propidium iodide. (D) The remaining number of ’live cells’ were
counted using the manufacturer’s cell counting protocol. The plot shows 5 replicates of
>50,000 cells each (red) and the average live cell count at each time point (black).
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Figure B.2. Quantification of surface and cytoplasmic Fn14. Fn14 overexpressing cervical
carcinoma HeLa cells were seeded at 37°C and surface proteins were biotinylated. Cells
were then detached either immediately after biotinylation (0 min) or after 15 and 30 minutes
of culturing. Whole cell lysates were prepared and either directly (Lysate) or after biotin
pulldown using NeutrAvidin beads analyzed by Western blotting for the indicated proteins
[Gurunathan et al., 2014] (the western blots can be found on Figure 2F o f the publication).
The bar chart shows Fn14 blots quantified using ImageJ gel blot analyzer, normalized
against EGFR levels and further normalized against whole cell lysate Fn14 level. The 0 min
’surface biotinylated’ blot represents the surface Fn14 level while 0 min ’whole cell lysate’
blot represents the total cell Fn14 level.
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A NOTE ON SPATIAL EFFECTS IN SIGNALING PATHWAYS
Spatial distribution of molecules can be of critical importance to cellular pathways.
Signaling events initiated within the two dimensional plane of the membrane move through
the three dimensional volume of the cytosol and propagate through multiple intracellular
compartments. The simplest signaling model ignores transport limitations and defines each
reaction step simply in terms of mass-action kinetics. This removes all partial differential
equations and results in a purely ODE based model. On the other hand, the most complex
model accounts for the diffusivity of each protein throughout the various sub-cellular
compartments resulting in a large number of PDE's and ODE's. The model presented
in this dissertation takes an intermediate approach where each cell is divided into three
'com partm ents' and protein transport rate is only considered when the protein moves
from one compartment to the other (Figure N1). Protein-protein interactions within a
compartment are assumed to be free of transport limitations.

Membrane Compartment

Diffusion rates defined

Cytoplasmic Compartment

Diffusion rates defined

Nuclear Compartment

Figure C.1. A simplified pathway schematic is shown on the left. The cell is divided
into three compartments: membrane, cytoplasm and nucleus. Signaling steps for which
diffusion rates are defined are shown with red arrows. However, within each compartment,
transport limitations are ignored.
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The justification for this approach lies in the fact that transport of a protein across
the plasma membrane or the nuclear envelope is in general one to two orders of magnitude
slower than diffusion within a compartment [Cowan et al., 2012; Timney et al., 2016]. To
demonstrate this, we may compare the approximate flux of the NF kB protein across the
nuclear membrane with the flux of NF kB from the edge of the nucleus to the center of the
nucleus. The flux across the nuclear membrane [Timney et al., 2016] can be approximated
as follows:

Fm —Dm(Ccytoplasm Cnucleus)

( 1)

Where, Dm is the diffusion coefficient for the movement of NF kB across the nuclear
membrane and C represents the concentration of NF kB. Dm was calculated by Timney et
al. [Timney et al., 2016] for 50kDa proteins (like NF kB) to be 1.86 x 10- 8m/s. Assuming
a cytoplasmic concentration of 50 uM (0.05 mol/m3) and a nuclear concentration of 0 uM
(fastest diffusion scenario), the flux is approximated to be:

Fm — 1.86 x 10-8(0.05 - 0) —9.3 x 10-10m ol/m

(2 )

Similarly, the flux of NF kB from the inside edge of the nucleus to the center of the
nucleus is approximated as follows:

dCnucleus „ ACnucleus „ Cnucleus C0
Fn — Dn---- :------ « Dn-----:------ —Dn----------------Ax
r
dx

(3)

Where, Dn is the diffusivity of NF kB in the nucleoplasm, C0 is the concentration of NF kB
in the center of the nucleus and r is the radius of the nucleus. Dn for nuclear proteins was
approximated [Kuhn et al., 2011] to be 1.72x 10- 11 m 2/s and the typical radius of mammalian
nuclei can be assumed to be 3 um. The flux of NF kB in the nucleus is therefore:

Fn — 1.72 x 10- i i °- 005 - 0 —3 x 10-8m ol/m 2
3 x 10- 6
'

(4)
v'
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The flux of NF kB across the radius of the nucleus is therefore about 2 orders of
magnitude higher than the flux across the nuclear membrane. Furthermore, the result as
sumes NF kB must move across the entire radius of the nucleus to reach the chromosomal
matter; for transport over a comparable distance as the thickness of the nuclear membrane,
the flux is over 5 orders of magnitude higher than the flux across the membrane. This calcu
lation supports the assumption that transport effects on protein-protein interactions within
a cellular compartment are significantly lower than the much higher transport limitations
placed by membranes separating the various compartments.
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